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Demographic changes in the 20th century have led to a drastic rise of the mean age 
at which women deliver their first child. This can be attributed to higher 
educational levels and increased participation of women in the working process, 
alongside with the introduction of reliable and easy available contraceptive 
methods. The overall incidence of infertility has remained relatively unchanged over 
the past three decades.  
 
What did change was the evaluation and the treatment of sub-fertile couples. The 
introduction of several assisted reproductive techniques (ART), for example In vitro 
fertilisation treatment (IVF), have led to an improved prognosis and as a result a 
structured diagnostic work-up. Furthermore, the more individualistic society 
together with the greater media attention for health matters in general and fertility 
issues in particular, have led to an increased demand for advice, evaluation and 
treatment. 
Nowadays, approximately ten percent of Dutch couples (van Balen et al. 1997) 
suffer from a fertility disorder and about half of them are treated with IVF or 
intracytoplasmic sperm injection (ICSI). As a consequence, one out of every 55 
children born in the Netherlands is conceived through IVF (Kremer et al. 2002). 
 
In the Radboud University Medical Centre more than 1000 IVF cycles are started. 
The medical procedure is more or less standard. A long IVF protocol is currently 
used. Pituitary down-regulation is achieved through a GNRH analogue 
(Decapeptyl®, Ferrring, Hoofddorp, the Netherlands). Ovarian hyper-stimulation is 
realized with recombinant follicle stimulating hormone (Puregon®, Organon, Oss, 
The Netherlands).Thirty-six hours after the injection with human chorionic 
gonadotropin (Pregnyl®, Organon, Oss, The Netherlands) trans-vaginal oocyte pick-
up (OPU) is performed. The morning after injection or insemination the fertilisation 
of the oocytes is evaluated. Three days after OPU one or two of the best quality 
embryos are transferred. The luteal phase is supported by intravaginal progesterone 
for fifteen days after OPU (Progestan®, Organon, Oss, the Netherlands). 
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I Prediction 
Over the years several models have been published to predict the chance of 
pregnancy both spontaneously (Eimers et al. 1994) and after IVF (Templeton et al. 
1996). The models consist of factors that were found to be related to pregnancy; 
age, duration of infertility, and type of infertility. Unfortunately, these models tend 
to be population specific and should therefore be tested in another population 
before being implemented elsewhere. In IVF age was at first found to be the best 
predictor of treatment outcome (Templeton et al.1996). On the other hand, the 
variability in ovarian ageing in the general population suggests that chronological 
age is a relatively poor indicator of the ovarian age in the individual. Furthermore, 
the costs, logistics and risks involved with IVF and the importance of accurate 
prognostication, have stimulated efforts to find other more accurate factors. Given 
the fact that fertility was shown to decline over the age of 30 (Schwartz et al. 1982) 
and an increased decline in women in women over 35 years of age (van Noord-
Zaadstra et al. 1991), it was logical to look for markers related to this assumed 
decline in ovarian reserve (te Velde et al. 2002).  
It is important to note that becoming pregnant is a complex multifactorial process 
and the size of the follicle cohort is more closely related to ovarian response than to 
the chance of pregnancy. Age was found to be related to a decline in both quality 
(Volarcik 1998) and quantity (Faddy 1992) of the ovarian pool. The declining oocyte 
quantity is associated with menopausal transition and menopause. The quality of 
the ovarian pool is related to pregnancy and fertility. The deterioration over time is 
attributed to accumulation of damage, such as oxidative stress (Tarin 1995). The 
fact that lower pregnancy rates (both after IVF and spontaneously) were found in 
women after exhibiting a poor response in IVF implies a direct relation between 
quality and quantity of the follicle pool (Lawson et al. 2003). On the other hand 
younger poor responders have shown reasonable pregnancy rates (Hanoch et al. 
1998). The relation between the quantity and the quality of the ovarian pool 
therefore needs further exploration. 
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Figure 1: relation between age and quantity and quality of the ovarian pool 
(according to: van Rooij, thesis 2003) 
 
Hormonal measurements in the early follicular phase were found to be associated 
with ovarian reserve. Ovarian reserve is defined as the number of primordial 
follicles. FSH is believed to indirectly reflect the size of the antral follicle cohort. 
Elevated concentrations of FSH in blood were found to be associated with poor 
ovarian response in IVF (Muasher et al. 1998). Since the growth of antral follicles is 
totally dependent on FSH, it was hypothesized that FSH-isoforms could provide 
additional information. Inhibin B levels decline before FSH levels rise, therefore low 
Inhibin B concentration in blood was suggested to be an even earlier marker of 
diminished ovarian reserve (Seifer et al. 1997). Basal ultrasound measurements of 
antral follicle count (Chang et al. 1998) and ovarian volume (Syrop et al. 1999) were 
introduced as direct morphological markers of ovarian reserve. Anti-Mullerian 
hormone is solely produced by granulosa cells (Baarends et al. 1995, Rajpert-De 
Meyts et al. 1999) and it reflects the pool of (pre)antral follicles. It was therefore 
introduced as a marker of ovarian reserve by van Rooij et al. (2002).  
The clomiphene citrate challenge test is a dynamic stimulation test and considered 
to be an even more sensitive test. In a subgroup of our population no predictive 
capacity of this test was found (unpublished data), as a result we did not include 
this test in additional research.  
 
In part one of this thesis pre-treatment factors, currently being presented as 
reliable and useful tools in the work-up of infertile women were evaluated and a 
new marker, FSH-isoforms, was tested.  
 
Age 
Quantity Quality 
- - 
? 
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II Stress  
The hypothesis of the relationship between fertility aspects and psychological issues 
has come a long way. There is controversy whether psychological distress causes or 
results from infertility (Stanton et al. 2002). In former days, psychogenic infertility 
was practically used as a synonym for medically unexplained infertility (Batstra et 
al. 2002). However, advancements in diagnostic, therapeutic and scientific 
methodology in infertility matters can no longer sustain this simplistic view 
(Wischmann 2003).  
Infertility is a chronic stressor that frequently endures for several years (Domar et 
al. 1993) and can be characterised as threat, uncertainty, uncontrollability and 
loss. These aspects may easily evoke anxiety (Stanton & Dunkel-Schetter 1991) and 
uncontrollability may result in depressive feelings (Seligman 1975).  
The number of couples taking advantage of IVF has increased considerably in the 
last decade. The success rate did not show the same increase and is currently just 
over 50% cumulatively after three attempts. This implies that increasing numbers 
of couples will be faced with unsuccessful treatment, leaving few or no treatment 
alternatives. The IVF treatment is associated with far greater anxiety than other 
fertility treatments, due to the last chance notion. (Dennerstein & Morse 1988, Litt 
et al. 1992). The stress of infertility is further reflected by the fact that half of all 
women experience fertility problems as being the worst event that has ever 
happened to them (Mahlstedt et al. 1985) and infertility was defined as a disease by 
the World Health Organisation. A special meeting on this topic, dealing with the 
medical, psychological, ethical and social aspects was organised by the WHO in 
2001 (www.who.int/reproductive-health/infertility).  
Not only psychological responses to infertility and assisted reproductive 
technologies (ART), but also psychological issues related to treatment outcome in 
ART are the subject of numerous studies. Furthermore, coping strategies and stress 
management interventions in ART were developed and studied to improve the well-
being of the patient. 
 
Outcome 
In the ‘Guidelines for Counselling in Infertility’ by the ESHRE it was stated that 
‘unexplained infertility is not in most cases equivalent to psychogenic infertility’ 
(Boivin 2002). On the other hand, evidence is mounting that stress may alter 
biomedical processes relevant to reproduction and therefore exert an effect. In most 
Chapter 1 
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studies stress was examined with standardized questionnaires often on anxiety and 
depression before or during treatment, and where successful outcome of treatment 
was defined by pregnancy. Higher levels of anxiety or depression were associated 
with lower pregnancy rates (Demyttenaere et al. 1998, Domar et al. 1999, Kee et al. 
2000, Klonoff-Cohen et al. 2001, Sanders & Bruce 1999). Others could not find this 
association (Ardenti et al. 1999, Csemiczky et al. 2000, Harlow et al. 1996, Slade et 
al. 1997).  
Almost all studies were performed in a (clinical) treatment setting, mostly related to 
in vitro fertilization treatment. Unfortunately, only the minority of the studies have 
a more or less systematic approach. However, taking all available studies into 
account the picture emerges that stress could well be a co-factor in the outcome of 
treatment.  
 
Drop-out 
Relative high percentages of patients’ drop-out in IVF-treatment were reported for 
other reasons than running out of funds or physicians telling them to discontinue, 
for instance psychological factors (Land et al. 1997). Additionally during treatment 
the psychological burden of treatment was found to be a major factor in patient 
drop-out (Olivius et al. 2004). Several authors reported drop-out rates up to 65% 
that were related to psychological factors (Hammarberg 2001, Olivius 2002, 
Osmanagaoglu 1999, Schroeder 2004).  
 
Mechanisms 
First a distinction has to be made between direct and indirect effects of stress. The 
direct effects refer to the autonomic nervous system, the (neuro) endocrine and the 
immune system. The indirect effects imply health changes affecting fertility 
resulting from changes in health behaviour (Vingerhoets & Perski 2000). 
The relationship between psychosocial stressors and the effects on the sympathetic 
medullar system and the hypothalamic-pituitary-adrenal (HPA) axis was subject of 
numerous studies throughout the years. However, studies linking the sympathetic 
system and the HPA axis with (in)fertility are scarce (e.g. Sanders & Bruce 1997). 
Thus, the relationship between stress, the release of hormones and the effects on 
fertility remain obscure and as a result only few psychobiological mechanisms were 
published. 
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Direct effects 
Stress could interfere with fertility via inhibition of the GnRH pulse generator in the 
hypothalamus (Ferin et al. 1999). Catecholamines may affect uterine blood flow 
(Schenker et al. 1992), and/or steroid genesis by granulosa cells and oocyte quality 
(Michael and Cooke 1992). Higher serum cortisol/follicular cortisol ratio was 
associated with higher pregnancy rates (Lewicka et al. 2003), whereas subfertile 
women were found to have elevated levels of cortisol compared to fertile controls 
(Csemiczky et al. 2000). Furthermore, stress was found to be associated with 
activated T-cells and reduced implantation (Gallinelli et al. 2001). In conclusion: 
several hypotheses concerning the direct effects of stress on fertility were presented 
throughout the years, but no clear picture emerges. 
 
Indirect effects 
Changes in health behaviour due to stress, i.e. smoking, alcohol intake, or weight 
gain may also affect fertility and treatment success. Since the indirect effects were 
not an integral part of this thesis, only a synopsis of the most relevant literature is 
presented. 
The strongest evidence for a negative impact on fertility was found for smoking. All 
aspects of fertility were found to be affected, including number and quality of 
oocytes, percentage of fertilization, implantation, pregnancy and miscarriage (Crha 
et al. 2001, El-Nemr et al. 1998, Lintsen et al. 2005, Paszkowski et al. 2002). 
Alcohol consumption was found to be predictive of infertility in women over 30 
years in a large cohort study (Tolstrup et al. 2003). Both female and male alcohol 
consumption were found to have negative impact on the outcome of IVF (Klonoff-
Cohen et al. 2005). Obesity was found to interfere with fertility (Pasquali et al. 2003, 
Pettigrew et al. 1997). Furthermore reduced success rates during IVF treatment 
were found in obese women (Fedorcsak et al. 2004, Lintsen et al. 2005, Munz et al. 
2005, Spandorfer et al. 2004). 
 
Intervention 
Systematic evaluation of intervention in infertility counselling, so with a control 
group and follow-up, was only performed in 25 out of 380 studies (7%). In general it 
was concluded that pregnancy rates were unlikely to be affected by psychosocial 
interventions. Relaxation techniques and interventions based on a behavioural 
medicine approach were found to increase pregnancy rates after ART treatment. 
Chapter 1 
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The evidence however being scarce, since only few controlled studies exist. 
Psychosocial interventions were more effective in reducing negative affect than in 
changing interpersonal functioning. Group interventions that had emphasized 
education and skills training were found to be significantly more effective in 
producing positive change across a range of outcomes than counselling 
interventions which emphasised emotional expression and support and/or 
discussion about thoughts and feelings related to infertility (Boivin et al. 2003).  
 
In part two of the present thesis psychological and biomedical factors were 
integrated and the relation with the outcome of IVF was studied. (see figure 2) 
 
 
Figure 2: Biopsychosocial model of fertility 
(according to: Verhaak, thesis 2003) 
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III Treatment 
IVF being the most invasive and intensive form of infertility treatment can obviously 
lead to distress. Patients even indicated that treatment is more of a psychological 
than a physical stressor since the outcome is unpredictable (Eugster et al. 1999).  
Previously a thesis on the ‘emotional impact of unsuccessful fertility treatment in 
women’ was published on the same cohort of women (Verhaak 2003). 
Factors that contribute to the emotional response to a severe stressor include 
personality characteristics (Clark 1994), biases in information processing (Williams 
1996), stressor-related cognitions (Beck & Clark 1997), coping (Lazarus & Folkman 
1984) and social support (Cohen & Wills, 1985). Based upon a stress vulnerability 
model a hypothetical course of women’s anxiety and depression in the event of 
unsuccessful treatment was launched. It was found that women with a passive 
coping style and cognitions of helplessness regarding fertility problems seem to be 
most vulnerable for developing severe emotional problems as the result of 
unsuccessful treatment. 
 
The assessment points of the present thesis are being indicated in figure 3. 
 
Before treatment (T1) 
In general, it may be concluded that at the start of the treatment, IVF patients with 
respect to depression levels did not differ from norm groups (Fekkes et al. 2003, 
Verhaak et al. 2001), while the results on levels of state anxiety were unequivocal: 
some studies showed higher levels (Salvatore et al. 2001, Slade et al. 1997), others 
showed no difference with the norm groups (Edelmann et al. 1994, Verhaak et al. 
2001).  
 
During one treatment cycle (T2)  
Several studies focussed on the emotional response during treatment. In general an 
increase in distress during the course of treatment was found and the oocyte-pick 
up and the pregnancy test were found to be the most stressful moments of the IVF 
cycle (Klonoff-Cohen 2001, Yong et al. 2000).  
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After one or more treatment cycles (T3)  
The most consistent finding in the literature was an increase in depression after 
one or more unsuccessful treatment cycles (Hynes et al. 1992, Lok et al. 2002), the 
picture regarding anxiety is equivocal (Slade et al. 1997, Visser et al. 1994). The 
observed stress response to failed treatment consists of a complex interplay of the 
acute burden of (failed) treatment and the chronic nature of the threatening 
definitive infertility (Verhaak et al. 2001).  
 
Follow-up (T4) 
Long term studies are lacking, but cross sectional studies showed less positive 
affect in women several years after (un)successful IVF (Hammarberg et al. 2001, 
Freeman et al. 1987). Longitudinal studies would make it possible to investigate the 
course of anxiety and depression, not only at several months post treatment, but 
also at long term follow-up. 
 
 
Figure 3: Study schedule  
Introduction 
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In part three of the study the pscychological consequences of IVF treatment were 
studied 6 months and at least 3 years after the last treatment cycle. 
 
Study design & objectives 
The present study consisted of a retrospective part, in which data were used from 
the Radboud University Medical Centre from 1991 up to 1999 to validate an 
existing model. In the prospective part patients were included between 1999 and 
2000. In total 380 patients were eligible and willing to participate. In 2003 the 
study was completed with a follow-up study of the cohort. Different selections of 
patients were used in different chapters. 
 
Next to the integration of biomedical and psychological factors and the mechanisms 
involved, the present thesis enabled us to do a follow-up on the implications and 
consequences of unsuccessful IVF treatment. An issue that receives a considerable 
amount of attention through clinical, descriptive and empirical studies.   
An overview of existing empirical research on emotional adjustment to IVF over the 
last 25 years was presented by Verhaak et al. (2006). Being informed about the 
long-term follow-up of women after definitively failed treatmen could indicate the 
need for additional research focussing on tailored interventions after treatment. 
 
The aim of this thesis was to study IVF by integrating gynaecological and 
psychological issues. Existing prognostic biomedical factors and models were 
chosen as the starting point. Since IVF is one of the more ‘controlled’ medical 
regimes, it was analysed whether these biomedical factors could explain the 
variance in treatment outcome. The first step was therefore to validate an existing 
model and other prognostic factors in a clinical setting. The next step was to 
integrate psychological factors and to biomedical factors in a prospective 
longitudinal cohort design to study additional explained variance in the outcome. 
Furthermore, the stress hormones were measured to study an explanatory 
mechanism. Lastly the consequences of IVF on the psychological outcome were 
studied in a prospective follow-up manner since the outcome of the process is more 
than that of cumulative pregnancy rates. Consequently, implications and 
recommendations for future treatment and future research are being discussed. 
Chapter 1 
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The thesis consists of three parts; 
I Study existing and new prognostic biomedical factors in IVF treatment 
II Study the integrated model of psychological and biomedical factors and  
the mechanisms involved on the course and outcome of IVF 
III Study the consequences of IVF on the psychological outcome and  
discuss recommendations for the future 
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Abstract 
 
This study aimed at externally validate the prognostic model presented by 
Templeton (1996) for a live birth resulting from IVF treatment. Data were used from 
the University Hospital, Nijmegen, the Netherlands, from March 1991 to January 
1999. The predictive capacity of the model in our population discriminated between 
a group of women that had a low probability of success and that had a relatively 
high probability. Despite these encouraging findings, our data show that 
implementation of the model in clinical decision making remains difficult. The 
‘Templeton’ model is not applicable nor usable in daily clinical practice, because the 
model did not give more information about the prognosis for the vast majority of the 
patients. The search for better prognostic factors resulting in better predictive 
models should therefore continue.  
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Introduction 
Modern medicine is more and more concerned with making choices from seemingly 
unlimited options. As a part of the decision making, for each individual, the 
physical, the psychological, as well as the financial costs should be weighed against 
the probability of success. Although it is practically impossible to predict the 
individual chance of a live birth in a couple accurately, prognostic models can help 
to encounter these matters in a rather objective way. They can also act as a 
convincing tool in individual counseling for both patients as well as physicians. It 
remains, however, to be seen how many patients refrain from treatment if their 
prognosticated chance is poor.  
In the field of infertility several authors have launched their models for the 
probability of pregnancy. Before any of these models can be implemented in clinical 
practice good external validation is required (Stolwijk et al. 1998). The predictive 
accuracy of a prognostic model can be expressed by calibration and discrimination 
(Harrel et al. 1996). Calibration refers to the amount of bias in the predictions, 
while discrimination refers to the ability to separate patients with different 
outcomes. Unfortunately, prognostic models after IVF for the probability of 
pregnancy presented in the literature have often not been validated (Haan et al. 
1991; Hughes et al. 1989; Templeton et al. 1996). Stolwijk et al. (1996) presented a 
prognostic model which was externally validated; these tests in another centre 
proved that these models could not predict well. Templeton et al. (1996) developed a 
model to predict pregnancy after treatment with in-vitro fertilization (IVF) by using 
data of 26,389 women treated in all IVF centres in the UK. Although a model based 
on such a large population seems rather confirmative, it might not predict well in 
other populations. To examine the external validation, a model should be applied to 
other data than those which the model was based upon. To our knowledge this 
external validation of the ‘Templeton model’ has not been done before. Therefore we 
started a retrospective study to validate the model and thereby estimate its clinical 
usability.  
 
Materials and Methods 
Data were used from couples who underwent their first IVF treatment after March 
1991 in the University Hospital Nijmegen, the Netherlands. All cycles, performed up 
to January 1999, were included. In concordance with the cycles included in the 
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study of Templeton et al. cycles were excluded in which intracytoplasmic sperm 
injection was performed or in which donor gametes or frozen embryos were used.  
 
All cycles in which hormonal stimulation was initiated were included, regardless 
whether follicle aspiration or embryo transfer was performed. Ovarian stimulation 
was most often performed by means of a long protocol of gonadotrophin-releasing 
hormone agonist, that was started on day 21 of the previous cycle, followed by 
human menopausal gonadotrophin (HMG). In general three embryos were 
transferred, but since January 1997 a maximum of two were transferred.  
The predicted probability of achieving a live birth after IVF (P) was calculated by 
means of the model presented by Templeton et al.: P = 100  exp(y) / [1 + exp(y)].  
Where y was defined as y = -2.028 + [0.00551  (age - 16)2] - [0.00028  (age - 16)3] 
+ [i – (0.0690  no. of unsuccessfull IVF attempts)] - (0.0711  tubal subfertility) + 
(0.7587  live birth after IVF) + (0.2986  previous pregnancy after IVF which 
resulted not in a live birth) + (0.2277  live birth which was not a result of IVF) + 
(0.1117  previous pregnancy, not after IVF and which did not result in a live birth). 
Tubal subfertility and previous pregnancies were dichotomised in the model; 1 if 
applicable, 0 if not. The indicator ‘i’ was a value used to represent the infertility 
duration in years and was 0.2163 if the infertility duration was between 1 and 3 
years, -0.0839 if between 4 and 6 years, -0.1036 if between 7 and 12 years, and -
0.4179 if 13 years or more.  
 
Templeton`s model is based upon information from clinic forms which do not 
specify criteria for diagnosis, as pointed out by Craft & Forman (1997). The variable 
‘diagnosis’, as used in the model, is therefore the result of different work-ups and 
criteria. Furthermore, other variables were not specified at all. Because of these, we 
made a few assumptions to define the following variables in the model; 
1. Age: age of the woman at the specific IVF cycle. 
2. Duration of infertility: duration of subfertility at the first IVF cycle. 
3. Unsuccessful IVF attempts: the total number of previous IVF cycles in which no 
ongoing pregnancy was achieved.  
4. Previous pregnancy not resulting in a live birth: spontaneous abortion or an 
ectopic pregnancy. 
5. Tubal pathology: tubal pathology exclusively. 
Furthermore, because of limitations in the data available, we defined: 
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6. The predicted outcome: live birth. Because of incomplete follow up we assumed 
for our calculations that all ongoing pregnancies, which are pregnancies that 
continued for at least 12 weeks after embryo transfer, resulted in live births. 
We performed 3 external validations in which we intended to study the influence of 
different definitions by comparing the outcome of these 3 validations: 
A. Following the assumptions mentioned above. 
B. Woman’s age at the first IVF cycle (instead of at the specific IVF cycle). 
C. Tubal pathology exclusively or in combination with one or more other subfertility 
diagnoses (male factor, endometriosis, or cervical factor) (instead of tubal pathology 
exclusively). 
 
We evaluated the predictive performance of the model by means of (I) the c index, 
which indicates the overall discriminative performance (Harrell et al. 1982, 1996), 
and (II) compared observed and predicted proportions of success for groups with a 
low probability (below 5%, below 10%) and a high probability (20% or higher). We 
presented predicted proportions with mid-p exact 95% confidence intervals(CI) 
(Vollset, 1993). The c index (number of concordant pairs + 0.5  the number of tied 
pairs/total number of pairs) can be interpreted as the probability of a correct 
prediction for a random pair that comprises a woman with an ongoing pregnancy and 
a woman without an ongoing pregnancy. A c index of 0.5 indicates that the 
predictions made for the whole population are bad; such a prediction is comparable 
to a flip of a coin. A c index of 1 indicates the ability to make perfect predictions.  
 
Results 
In total the data of 1292 couples who started a first IVF treatment since March 
1991 in the University Hospital Nijmegen, the Netherlands, were used. Up to 
January 1999 they underwent 2756 IVF cycles. Of 35 couples who underwent 75 
cycles, the duration of infertility was unknown; of two of them the subfertility 
diagnosis was also unknown. Of another 3 couples, who underwent 5 cycles, it was 
unknown whether tubal pathology was present. Of one couple who underwent two 
cycles it was unknown whether any non-IVF live births were present. After 
excluding data of these couples, we could use the data of 1253 couples who 
underwent 2674 IVF cycles for the external validation of the model of Templeton et 
al.  
 
Chapter 2 
__________________________________________________________________________________________ 
 
 
38 
The mean age of the women at the beginning of treatment was 32.8 years(SD=4.0; 
range 22-44; median 33 years) and the mean duration of infertility was 3.7 years 
(SD=2.5; range 1-21; median 3 years). The mean number of previous unsuccessfull 
IVF attempts was 0.8 (SD=1.0; range 0-6; median 0 unsuccessfull attempts).  
In the validation 7% of the cycles were preceded by at least one previous live birth 
after IVF, 6 % by at least one previous IVF pregnancy not resulting in a live birth, 
13 % by at least one live birth (excluding IVF births) and 22 % by at least one 
pregnancy not resulting in a live birth (excluding IVF pregnancies). From all cycles 
that were used in the validation, 47% were first cycles, 29% were second cycles, 
16% were third cycles, 5% were fourth cycles and 2% were of a higher rank (range 
5-8). The distribution of indications for treatment, also important to test 
Templeton’s model, is depicted in Table I. 
 
Table I: Indication characteristics of the couples at the start of the first IVF cycle 
(n=1253). 
 
Indication for treatment Frequency (%) 
Tubal pathology exclusively 295 (23.5) 
Male factor exclusively 300 (23.9) 
Tubal pathology and male factor 60 (4.8) 
Other reasons* 338 (27.0) 
Idiopathic 260 (20.8) 
*Other reasons include hormonal, endometriosis, cervical  
factor, or a combination with tubal pathology or male factor 
 
In the first validation (A) in which we used the assumptions mentioned above, we 
found a c index of 0.629. In the second validation (B), where another way of 
defining the woman`s age was investigated, the c index was 0.632. In the third 
validation (C),  where we looked upon the effect of another way to define the 
diagnosis, we found a c index of 0.628. Using the assumptions of validation A, we 
calculated the predicted proportions.  
 
In Table II we present for each group of patients within a specific range of 
predictions (e.g. 0-<5%) the observed proportion of ongoing pregnancies with the 
95% confidence interval. The observed proportions increase from 0.0% in the group 
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with a predicted probability of 0-<5% to 37.0% in the group with a predicted 
probability of 30%. 
 
Table II: Predicted and observed probability of an ongoing pregnancy during an IVF 
treatment cycle (P) in the first validation. 
 
 Predicted probability (%) 
 0-<5 5-<10 10-<15 15-<20 20-<30 30 Total 
Observed         
Number of cycles 50 370 1116 924 187 27 2674 
Number of ongoing 
pregnancies 
0 34 179 180 67 10 470 
Percentage P  
(95% CI) 
0.0 
(0.0- 
5.8) 
9.1 
(6.5-
12.5) 
16.0 
(14.0-
18.3) 
19.5 
(17.0-
22.1) 
35.8 
(29.2-
42.9) 
37.0 
(20.6-
56.2) 
17.6 
(16.2-
19.1) 
 
In our population,  the women with a low predicted chance (<10%) are relatively old 
(34-45 years) and never had a live birth after IVF treatment. Of these, the younger 
ones (34-36 years) all had a history of infertility of 4 years or more. The women in 
our population with a fairly high predicted chance (20%) generally were younger 
(66% was younger than 34 years) and most of them (86%) had a history of infertility 
of 1-3 years. The group with a high predicted chance (30 %) is characterised by 
women who all had a previous live birth after IVF. 
 
Discussion 
The comparison of the predicted and observed chances of success (Table II) shows 
that the model seems to be able to identify the women with a low chance and the 
women who have a high chance of achieving a live birth. Our c indices of 
approximately 0.6, however, suggest a poor predictive performance of the 
‘Templeton model’. In general, about 13.9% of the IVF-cycles will be successful, 
according to Templeton. Without any information of a patient, this will be the prior 
probability of success. A prognostic model is useful if it changes this prior 
probability in an accurate way. In the population seventy-six percent had a 
(posterior) predicted probability of 10-<20%. Such a prediction does hardly change 
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their prior probability. Thus for the main proportion of patients the model of 
Templeton showed no use.   
 
In the model the relative importance of the presented factors can be deducted from 
the parameter estimates resulting from the multiple logistic regression model. 
The ‘duration of infertility’ as well as ‘previous pregnancies’ play an important role 
(in the latter the number of pregnancies is multiplied by the regression coefficient) , 
whereas the influence of the woman’s age is not so obvious. Therefore we made a 
calculation of the relative effect of the woman’s age. For this purpose we used the 
formula presented in the model: 0.00551  (age – 16)2  - 0.00028  (age – 16)3. 
 
Table III: Women’s ages and the resulting regression coefficients (Rc). 
 
Age Rc Age Rc Age Rc 
20 0.07024 28 0.30960 36 -0.03600 
21 0.10275 29 0.31603 37 -0.16317 
22 0.13788 30 0.31164 38 -0.31460 
23 0.17395 31 0.29475 39 -0.49197 
24 0.20928 32 0.26368 40 -0.69696 
25 0.24219 33 0.21675 41 -0.93125 
26 0.27100 34 0.15228 42 -1.19652 
27 0.29403 35 0.06859 43 -1.49445 
 
From Table III it becomes clear that 29 is the most favourable age to achieve a live 
birth after IVF, that the chance rapidly decreases when the patient becomes older 
and that the relative positive influence of low age decreases in younger women. 
Although the parameters used by Templeton et al. all contribute to the predictive 
capacity of the model, age still is a very important predictor. We could not find 
remarkable differences between the results of our original validation (A) and our 
second validation (B), suggesting that there is no significant influence of the 
definition of the woman’s age. This was expressed by the virtually unchanged c 
index (from 0.629 to 0.632). 
In our third validation (C) we compared the predictive value of tubal pathology in 
combination with other diagnoses as subfertility diagnosis with ‘tubul pathology 
exclusively’. The c index hardly changed (from 0.629 to 0.628). Therefore we 
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concluded that the exact definition of ‘tubal pathology’ as subfertility diagnosis 
plays a minor role. This can be explained by the low regression-coefficient for ‘tubal 
reasons for infertility’ in the ‘Templeton model’ (-0.0711).  
In our assumptions we chose to use ongoing pregnancy as our endpoint instead of 
live birth, because the follow-up of pregnancies was not accurately enough.  
Data from our own clinic show that from July 1991 till December 1997 506 ongoing 
pregnancies resulted in 482 live births (95%). The predicted probabilities for a live 
birth will therefore underestimate the expected probabilities of ongoing pregnancy. 
We observed for the entire population that in 17.6% of the started cycles an ongoing 
pregnancy was achieved. The model by Templeton et al. predicted that in 14.4% 
(95% CI= 13.1-15.7%) of the started cycles a live birth would be achieved. Craft & 
Forman (1997) pointed out that Templeton reported an unexplained infertility 
incidence of over 30%, which they felt is very high, considering that patients were 
treated in tertiary fertility referral centres. Our data show a considerable lower 
percentage (20.8%) of unexplained infertility cases. Last but not least, the original 
study revealed big differences between the contributing centres, what could 
attribute to the poor reproducibility of the model.  
The question raises whether the development of a better model is possible or not. 
Other promising predictive factors may increase the predictive value of a model, as 
pointed out by Craft and Forman (1997). For instance basal FSH (Sharif et al. 
1998), or day 3 estradiol (Smotrich et al. 1995) showed better predictive value than 
age alone. Inhibin is regarded to be another promising predictor of the outcome of 
IVF (Lindheim et al. 1998; Seifer et al. 1997). Moreover, since new techniques and 
medication influence the results of assisted reproductive technologies, a prognostic 
model has a limited lifetime and needs constant adaption.  
 
In conclusion: the model presented by Templeton et al. based upon an unrivalled 
large dataset, seems to be able to discriminate a group of women with a very low 
and those with a very high probability of achieving success after IVF in our 
population. However, for the majority of women the application of the Templeton 
model did not give any more certainty, because their prior and posterior 
probabilities hardly differed. 
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Abstract  
 
Antimüllerian hormone (AMH) and other markers of ovarian reserve were assessed 
to determine their predictive value with respect to treatment outcome. In a 
multivariate regression analysis AMH was found to be predictive of the number of 
oocytes and the number of embryos, but not of embryo quality or the chance of a 
pregnancy after IVF/ICSI. 
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Introduction 
In IVF/ICSI treatment outcome is highly variable and difficult to predict. The 
reproductive function is related to age, but age is an inaccurate predictor of ovarian 
reserve. Indicators of ovarian reserve would candidate as predictors for the 
probability of an ongoing pregnancy after IVF/ICSI. With menopause being a rather 
clear endpoint of reproductive function, ovarian reserve is far more difficult to 
specify. It is often considered a clinical diagnosis: poor response, defined as a low 
number of follicles despite high dosages of gonadotrophins. 
  
Since in counselling it would help both patients and doctors to be informed about 
the chances of a pregnancy, spontaneously or resulting from assisted reproductive 
technologies (ART), indicators of ovarian reserve have been sought and  have been 
introduced in clinical practice. Basal hormonal tests measured in the early follicular 
phase; e.g. elevated FSH concentration in blood (Muasher et al. 1998), low Inhibin 
B concentration in blood (Seifer et al. 1997) have been suggested, but also basal 
ultrasonographical measurements, e.g. antral follicle count (AFC) (Chang et al. 
1998), ovarian volume (OV) (Syrop et al. 1999), were found to be associated with 
ovarian reserve. However, for all these markers the predictive power appears to be 
low. Recently, a potentially new marker was put forward: antimüllerian hormone 
(AMH) (van Rooij et al. 2002).  
Antimüllerian hormone is expressed after birth in the granulosa cells of healthy, 
small growing follicles (Baarends et al. 1995). It plays (in)direct roles in various 
phases of folliculogenesis, from the primordial to FSH-sensitive follicular stages 
(Durlinger et al. 2002, McGee et al. 2001). AMH serum levels were shown to 
correlate strongly with the number of antral follicles (Gruijters et al. 2003) and it 
has a relative stable expression during the menstrual cycle (Cook et al. 2000). Seifer 
et al. (2002) found a correlation between AMH serum levels and the number of 
oocytes retrieved during IVF treatment. AMH is by now presented as a good marker 
of the ovarian reserve (Visser and Themmen 2005).  
 
To study the predictive value AMH conditional on other alleged predictors of 
treatment outcome, we included these different markers in a prospective study 
among couples treated with IVF/ICSI and correlated these with clinical outcomes, 
such as the number of follicles, number of embryos, embryo characteristics and 
probability of an ongoing pregnancy. 
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Materials and methods 
Patients 
Patients who started a new IVF/ICSI treatment at the Radboud University Nijmegen 
Medical Center, an academic tertiary referral centre in the east of the Netherlands 
were invited to participate in the study. Inclusion criteria were: age < 42 years, 
regular menstrual cycles, both ovaries present, no endocrine disorders. A long 
protocol with Decapeptyl® (Ferring, Hoofddorp, the Netherlands), Puregon® 
(Organon, Oss, the Netherlands) and Pregnyl® (Organon, Oss, the Netherlands) was 
used. Only first treatment cycles were included. A maximum of two embryos was 
transferred, three days after ovum pick up (OPU). Informed consent was obtained 
from 112 participants. This study was approved by the ethical committee of the 
institution. All participants were guaranteed confidentiality, and only the principal 
investigator (JS) had full access to the data. 
 
Blood sampling and hormone measurements 
On cycleday 3 before treatment, that is before the start of GnRH-analogue 
medication, women were monitored on predictiors of treatment outcome. Serum 
basal follicle stimulating hormone (FSH), Inhibin B and AMH were determined and 
ultrasound was performed measuring the antral follicle count and total ovarian 
volume. 
Blood was collected by venapunction in dry tubes and serum was separated and 
frozen in aliquots at -20ºC. Follicular Stimulating Hormone (FSH) in serum was 
determined by Fluorescence Immunoenzymometric Assay using a random access 
analyser (AxSYM, Abbott, Hoofddorp, the Netherlands). Serum inhibin B levels were 
measured using an ultrasensitive enzyme-linked immunosorbent assay (ELISA) 
(Serotec, Oxford, UK). Serum AMH levels were determined using an enzyme 
immunoassay kit (Immunotech, Marseille, France). 
Ovarian ultrasound scanning was performed on the same day as the bloodsampling 
by one operator (J.S.) who was blinded to the results of the hormone assays. The 
sum of all follicles measuring 2-10 mm in mean diameter in both ovaries was 
established. Ovarian volume was calculated with the equation of an ellipsoid (0,526 
x length x height x width) (Sharara and McClamrock 1999).  
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Outcome 
Main outcome measure was a viable pregnancy. This was defined as a positive 
heartbeat on transvaginal ultrasound five weeks after embryotransfer (ET). 
Secondary outcome measures were: number of oocytes, number of embryos and 
quality of the embryos.  
The embryo quality was dichotomized (good versus bad) based upon a composite 
score consisting of amount of fragmentation and the number of cells of the best 2 
embryos (if applicable). Embryos with less than 20% fragmentation and 7 or more 
cells were defined as ‘good’ (Fisch et al. 2001).  
 
Statistical analysis 
Data analysis was performed by means of the SPSS-program (version 11.0 for 
windows, SPSS INC., Chicago, USA). For reasons of efficiency and costs, we 
compared all women who became pregnant (n=40) with an equal number (40 out of 
72) of non-pregnant women. 
For univariate comparison of the two independent samples we used the Mann-
Whitney test, with respect to the non normal distribution of markers. The 
Spearman correlation coefficient was used to estimate the association between the 
different markers. A multivariate logistic regression analysis was used to find the 
best combination of independent predictors for clinical outcomes. 
 
Results 
One-hundred-and-twelve women were assessed on cycleday 3 prior to treatment. 
Forty (36%) achieved a viable pregnancy. These 40 patients were retrospectively 
compared with 40 randomly selected women out of the 72 remaining women 
without a pregnancy.  
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Table I: Population characteristics and markers of ovarian reserve  
 Parameter 
values (range) 
N=80 
Pregnant 
women (SD) 
N=40 
Nonpregnant 
women (SD) 
N=40 
p-value 
Age (years) 27.6-41.9 34.1 (3.1) 34.9 (4.1) .36 
Body Mass Index (kg/m2) 16.9-39.1 23.8 (3.3) 23.8 (4.3) .95 
Gonadotropins (IU) 800-5700 1854 (933) 2102 (942) .24 
Number of oocytes 1-30 10.7 (6.6) 10.1 (5.0) .65 
Number of embryos 1-22 6.7 (4.7) 6.3 (4.5) .66 
Embryo quality score  1-2 1.4 (0.5) 1.4 (0.5) .65 
FSH (IU/L) 1.8-14.4 6.6 (2.4) 7.0(1.9) .50 
Inhibin B (pg/mL) 5-161 87.3 (31.2) 95.8 (38.4) .28 
AMH (g/L) 0.2-11.7 3.2 (2.6) 2.9 (2.4) .49 
Antral follicle count (n) 1-25 8.6 (4.2) 7.3 (3.6) .14 
Ovarian volume (cm3) 1.6-24.8 6.3 (3.9) 6.0 (3.1) .72 
 
Table I shows patient characteristics and the ovarian reserve markers of pregnant 
and nonpregnant women. No statistically significant differences in any of these 
markers could be detected in univariate analysis. 
AMH was found to be significantly correlated to the other predictors: FSH (r=-.42; 
p<.01), AFC (r=.52; p<.01), OV(r=.38; p<.01), but not with Inhibin B (r=.08; p=.47). 
 
All these markers were included in a logistic regression analysis with pregnancy 
probability as primary outcome, thus including all 80 women in this study. The 
analysis did not reveal any meaningfull predictive capacity for any of the markers of 
ovarion reserve. In a similar logistic regression analysis, AMH proved to be 
predictive of the number of oocytes (t=2,5; p=.02) and the number of embryos 
(t=2.0; p=.05). The other reserve markers were not found to be significantly 
independently predictive of the number of oocytes or embryos. None of the factors 
showed predictive capacity with respect to the quality of embryos. 
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Discussion  
In the present study serum AMH levels were found to be variable (range 0.2-11.7) 
and associated with ovarian responsiveness, but not with embryo quality and not 
with the probability to achieve a pregnancy. Other markers of ovarian reserve 
(biomedical, echoscopic and hormonal) were found to have an even poorer capacity to 
predict the number of oocytes, number of embryos, embryo quality or pregnancy after 
treatment. 
 
The requirements for the ideal marker reflecting the decline in reproductive function 
are: biological plausibility, cross-sectional relation with age, mean longitudinal 
change and consistency of individual change (according to: van Rooij et al. 2005). 
Basal FSH seemed to fulfill all criteria and was subject of many studies. However, in 
a review, Bancsi et al. (2003) concluded that basal FSH should not be regarded as a 
useful routine test for the prediction of IVF outcome. AMH was launched as a new 
marker of ovarian reserve by the same group (Van Rooij et al. 2002).  
 
Fanchin et al. (2003) showed higher correlations for serum AMH levels and antral 
follicular count than for serum levels of inhibin B, FSH, estradiol and LH. We also 
found a high correlation between AMH and AFC, but the correlation-coefficient (0.52) 
was lower than previously reported i.e. 0.71 in 41 normal ovulatory women and 13 
postmenopauzal women (De Vet et al. 2002) and 0.74 in 75 infertile patients (Fanchin 
et al. 2003).  
Several other studies have researched the capacity of AMH to predict ovarian 
response and the chance of a pregnancy. Tremellen et al. (2005) concluded in a study 
in 87 women undergoing IVF that AMH assessments are superior to FSH in 
identifying women with reduced ovarian reserve compared with women with a normal 
reserve.  
Penarrubia et al. (2005) found in studying 80 women, that AMH concentrations 
obtained early during ovarian stimulation under pituitary suppression for assisted 
reproduction are better predictors of ovarian response than basal measurements of 
AMH.  
Hazout et al. (2004) demonstrated  a strong association between day 3 serum AMH 
levels and the number of mature oocytes, the number of embryos and clinical 
pregnancy rates in 109 IVF patients.  
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Muttukrishna et al. (2004) also found in a study in 69 IVF patients that compared 
with FSH and Inhibin B, AMH is the best single marker of ovarian response to 
gonadotrophin stimulation in terms of number of women with poor response and 
number of eggs collected in IVF cycles.  
Van Rooij et al. (2005) have shown in a longitudinal study of 81 patients who were 
followed for about four years that AMH is a fairly good endocrine marker for the age-
related decline of reproductive capacity. 
  
In conclusion, although AMH is correlated with ovarian reserve and hence candidate 
for use as a predictor, its predictive capacity is too limited to be of clinical value. Only 
the number of oocytes during egg retrieval and the number of embryos, but not the 
chance of a pregnancy could be predicted.  
 
So in contrast to the stimulation phase, the implantation phase remains more or less 
a black box. Clinicians seem unable to influence the outcome in this phase, as they 
are grossly unaware of the mechanisms involved. One of the rare factors that was 
found to be related to pregnancy after the implantation phase was embryo quality. 
Embryo quality might be affected by oxidative stress (Agarwal et al. 2005), but even 
morphologically normal embryos could show an abnormal number of chromosomes 
and low pregnancy rates (Twisk et al. 2006). 
 
In the sparse literature on this topic it was reported that AMH at the time of HCG 
administration was positively correlated with the embryo score (Silberstein et al. 
2006). Our observation that basal AMH is not related to embryo quality could 
contribute to an explanation for the low correlation with pregnancy probability, as 
embryo quality is crucial for clinical success (Schmidt et al. 2005).  
These seemingly contradicting findings might be explained by the different 
assessment points during treatment, stressing the fact that additional research is 
needed. 
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Abstract 
 
The objective of this study was to determine the predictive value of FSH-isoforms for 
the outcome of IVF treatment. Although this pilot study comprises only a small 
number of patients, we conclude, since no statistical differences could be found in 
the isoform-composition between poor and good responders, that it is not likely that 
FSH-isoforms predict treatment outcome after IVF.  
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Introduction 
In in-vitro fertilization (IVF) programmes, treatment outcome is highly variable and 
difficult to predict. Ovarian responsiveness to gonadotropins and number and 
quality of embryos after fertilization still is  unpredictable. However, to be able to 
optimise patient counselling and make best use of restricted resources, the search 
for predictors of treatment outcome is still ongoing (Templeton et al. 1996, Stolwijk 
et al. 1996). Unfortunately it is still not possible to create a model to predict 
treatment outcome accurately (Smeenk et al. 2000). 
Follicle-stimulating hormone (FSH) is the most frequently studied basal hormonal 
predictor, assessed before pituitary down-regulation. It was reported to have 
additional predictive value or even better predictive value than age alone (Muasher 
et al. 1998). On the other hand, Bancsi et al. (2003) concluded in a meta analysis 
that the clinical value of testing basal FSH concentrations is restricted to a minority 
of patients. Recently Hendriks et al. (2005) concluded that antral follicle count 
might be considered the test of first choice in the assessment of ovarian reserve 
prior to IVF. 
 
FSH is a heterodimer composed of an alpha and beta-subunit with glycosylation 
sites located on each of the subunits. The oligosaccharide attached to the FSH 
molecule terminates in a negatively charged residue, thereby forming a variety of 
isoforms which differ in their isoelectric points. The acidic isoforms were found to 
have a reduced bioactivity as assessed by its potency to stimulate cyclic AMP 
production and a longer half-life time in the circulation compared to the less acidic 
isoforms (Baird 2001; Lambert et al. 1998).  
The distribution of FSH isoforms in blood varies throughout the menstrual cycle 
and during life (Anobile et al. 1998). There is increasing evidence that the extent 
and pattern of glycosylation is under hormonal control (Ulloa-Aguirre et al. 1988). It 
was suggested that different glycoforms may encode for different functions or have 
enhanced activity for a particular function (Padmanabhan 1995).  
Oestradiol concentrations were associated with less acidic FSH glycoforms during 
the menstrual cycle. The menopause oestrogenic loss was found to result in acidic, 
relatively simple glycoforms (Anobile et al. 1998). Similar findings were reported by 
Flack et al.(1994) and Creus et al.(1996). 
 
Chapter 4 
__________________________________________________________________________________________ 
 
 
60 
Since the growth of antral follicles is totally dependent on FSH, it was hypothesized 
that not only the quantity but also the quality of FSH, in terms of isoforms  plays an 
important role in the early follicular phase. In a recent discussion it was suggested 
that the FSH isoform composition of commercial gonadotropin preparations is of 
clinical importance and should be taken into account when evaluating treatment 
efficacy (Andersen et al. 2004), which further underlines the independent role of 
FSH isoforms. 
In our clinic FSH is the only clinically meaningful hormonal predictor. Women with 
high pre-treatment levels of FSH (> 10 IU) are treated with increased dosages of 
gonadotropins and patients older than 41 years of age are not treated at all. Since 
the sensitivity of FSH levels in predicting a poor response was low, we hypothesized 
that the acidity of the FSH could provide valuable additional information on the 
prognosis of patients, which we would miss by just regarding the concentration of 
total FSH-immunoreactivity.  
The aim of this study was therefore to assess the role of FSH-isoforms with respect 
to treatment outcome of the IVF procedure. 
 
Materials and methods 
 
Patients and treatment  
A total of 156 women started their first cycle of IVF treatment. The IVF protocol was 
similar for all patients. In all patients both ovaries were present. The treatment 
consisted of a long protocol of pituitary down-regulation with an agonist 
(Decapeptyl®, Ferring, Hoofddorp, the Netherlands) starting at day 21 of the 
previous cycle, followed by ovarian stimulation with recombinant human 
gonadotrophin (Puregon®, Organon, Oss, the Netherlands).  
Oocyte retrieval by transvaginal ultrasound-guided puncture was performed 36 h 
after human chorionic gonadotrophin (Pregnyl®, Organon, Oss, the Netherlands) 
administration. Forty-eight hours after ovum retrieval and fertilization, no more 
than two embryos were transferred into the uterine cavity and this was followed by 
luteal support with Progestan® (Organon, Oss, the Netherlands). According to the 
protocol, young patients received a fixed daily dosage of 150 IU and older patients 
(over 37 years) received a fixed dosage of 300 IU recombinant FSH daily.  
For reasons of efficiency and costs, the present pilot study comprised two groups of 
five women. Two homogenous but clearly distinct groups were selected to 
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investigate additional predictive value of the FSH-isoforms. Inclusion criteria of the 
response and poor response group comprised age (young versus significantly older), 
response to FSH treatment (150 IU versus 300 IU), and outcome (pregnancy versus 
no pregnancy) of the IVF treatment. Patients were screened on day 3 of the cycle 
preceding the IVF-treatment cycle.  
The following data were collected: age, body-mass index (BMI), serum FSH 
concentration and antral follicle count (AFC). Serum was obtained and stored at 
minus 20 degrees Celsius until further processed.  
Outcome variable was the number of oocytes. Poor response was defined as less 
than 4 follicles of 15mm or more, during stimulation. 
 
Determination of FSH isoforms 
A fast performance liquid chromatography (FPLC) sytem (Pharmacia) equipped with 
a 4 ml Mono-p column was used for chromatofocusing of FSH to determine its 
isoforms. To exchange the storage counter ion of the column the resin was washed 
with 2 ml of a 2M NaCl solution and then equilibrated at a flow rate of 0.5ml/min 
with 30-50ml starting buffer (7.14 mM bis-tris, pH 7.3-7.4) until the effluent pH 
was equal to that of the starting buffer. The 2.5-ml serum specimens were desalted 
on a PD-10 column (Pharmacia), degassed, eluted with bis-tris starting buffer and 
made up to 10 ml with this buffer. Next, 8.5 ml of the sample was loaded onto the 
column and the pH gradient generated by introducing the Polybuffer 74 (Pharmacia) 
elution buffer at a flow rate of 0.5 ml/min. One-hundred-forty 1-ml effluent 
fractions were collected and pooled at a pI < or > 4.3, defined as a relevant pH cut-
off point (9). The lowest detectable concentrations (0.15 IU/L) of FSH fell within the 
working range of the FSH immunoassay (AxSYM, Abbott) and mean recovery from 
the Mono-P column varied between 94 ± 8.5 (SD) % and 97 ± 4.2 (SD) %. The acicity 
of FSH-isoforms was expressed as a ratio of the proportion of isoforms with 
pH>4.3/the proportion of isoforms with pH<4.3 
 
Statistical analysis 
Non parametric chi-square tests were used to compare groups. Significant 
differences were defined as a p-value <.05. 
 
Chapter 4 
__________________________________________________________________________________________ 
 
 
62 
Informed consent was obtained from all participants. This study was approved by 
the ethical committees of the institution. All participants were guaranteed 
confidentiality, and only the principal investigator (JS) had full access to the data. 
 
Results 
The ‘responder’ group of women (mean (SD) age: 30.8 (2.1)) had a normal FSH 
concentration, a good response to gonadotropins (and pregnant) after the first 
treatment cycle. The ‘poor responder’ group of women (mean (SD) age:38.6 (1.5)) 
had also normal FSH concentrations, with a poor response to gonadotropins, and 
consequently did not become pregnant after the first treatment cycle. 
The table depicts the pre-treatment variables of the groups of responders and non-
responders. Serum FSH, FSH isoforms and serum inhibin B were determined. 
 
Table I: Pretreatment variables (mean (SD)) in responders and non-responders  
 
 Responders Poor Responders P-value 
BMI 24.0 (1.6) 24.9 (5.8) .69 
Antral Follicle Count 7.2 (1.4) 3.4 (1.8) .01 
FSH 5.1 (1.5) 5.3 (1.6) .84 
FSH isoform ratio 1.3 (1.0) 0.9 (0.3) .44 
Inhibin B 94.8 (11.5) 22.0 (13.8) .00 
 
Responders and poor responders statistically differ in antral follicle count and 
Inhibin B concentrations in blood, but no pretreatment differences were found 
regarding FSH concentrations in blood and FSH-isoform ratios. 
 
Discussion 
In the present study FSH-isoforms were investigated in order to study their 
predictive value with respect to the response to gonadotropins in IVF/ICSI 
treatment.  
No statistical differences were found in the FSH isoform ratio between responders 
and poor responders to FSH treatment, suggesting no clinical relevant role of FSH-
isoforms to predict the outcome of IVF treatment. Our study appeared to show 
presence of more acidic and complex isoforms in the responder group of young 
women, but this difference did not reach statistical significance. 
Follicle-stimulating hormone isoforms are not useful as pretreatment predictors 
__________________________________________________________________________________________ 
 
 
63 
Several authors provided data suggesting different biological functioning of different 
FSH-isoforms. However, the literature data are not unequivocal. West et al. (2000) 
showed that more acidic FSH isoforms are better facilitators of follicular maturation 
and increased estradiol production than less acidic isoforms. However, Andersen et 
al. (2001) showed that less acidic isoforms were found to be twice as effective as the 
acidic isoforms in the production of cAMP in oocyte cumulus complexes from large 
preovulatory follicles.   
Furthermore, resumption of meiosis was found to be significantly more efficient if 
induction was performed with less acidic isoforms from the circulation (Andersen et 
al. 1999). Antonio et al. (1999) found a faster clearance of less acidic isoforms 
compared with the more acidic isoforms. Less acidic isoforms exhibited a higher in-
vitro biopotency than the acidic isoforms. Vitt et al. (1998) found that the least 
acidic isoform induced the fastest preantral growth, the largest antral follicles and 
had more impact on stimulation of estradiol production and antral formation than 
the more acidic isoforms.  
Next, in sheep, age and reproductive state were found to be associated with the 
forms of FSH that were extracted from the pituitary gland. Qualitative changes in 
FSH were found to be important in the physiological regulation of follicle turnover 
(Cooke et al. 1997).  
In short, more acidic FSH isoforms have a slower clearance from the circulation and 
consequently a longer half-life, but have a lower bioactivity compared with less 
acidic FSH isoforms. 
  
In our study Inhibin B concentration and antral follicle count, two known 
predictors of poor response significantly differed between the responders and the 
poor responders. FSH isoforms do not provide us additional information upon the 
response to gonadotropins. Although this could be due to stratification of the 
groups using a normal basal FSH concentration and age and to the limited sample 
size.  
 
No evidence can be provided that qualitive information on the FSH-isoforms 
predicts the ovarian response during IVF treatment. 
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Abstract 
 
Objective: This study aimed to clarify the role of depression and anxiety on the 
outcome in assisted reproductive treatment. Previous studies on this topic have 
shown contradicting results, which may have been caused by population 
characteristics, the design of the study, or small sample sizes.  
Methods: In a multicentre prospective study 281 out of 359 (81%) consecutively 
invited women were willing to take part. Before down-regulation by means of GnRH-
analogues in a long IVF-protocol, patients were asked to fill out the Dutch version of 
the State and Trait Anxiety Inventory to measure anxiety and the Dutch version of 
the Beck Depression  Inventory (BDI) to measure depression. Multiple logistic 
regression analysis was used to analyse known predictors of pregnancy and 
psychological factors and their relation with treatment outcome.  
Results: We showed a significant relation between base-line psychological factors 
and the probability to become pregnant after IVF treatment, controlling for other 
factors. State anxiety had a stronger correlation with treatment outcome than 
depression.  
In conclusion: pre-existing psychological factors are independently related to 
treatment outcome in IVF/ICSI and should therefore be taken into account in 
patient counseling. Psychological factors may be improved by intervention, whereas 
demographic and gynaecological factors cannot. Future studies should be directed 
towards underlying mechanisms involved and the role of evidence based distress 
reduction in order to improve treatment results. 
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Introduction 
Women undergoing in vitro fertilization (IVF) treatment are often anxious and 
depressed because of their infertility and the uncertainties of the treatment they 
have to deal with (Mahlstedt 1985). Indeed epidemiological and anecdotal data 
suggest a relationship between psychological factors and infertility (Freeman et 
al.1985;  Lapane et al. 1995). However, a systematic review of controlled studies 
before 1990 presented contradicting results (Wright et al. 1989). More recently, a 
review by Eugster and Vingerhoets (1999) indicated that the influence of 
psychological factors on the outcome of IVF/intra cytoplasmatic sperm injection 
(ICSI) still continues to be a matter of debate. In this review no particular attention 
to ICSI was paid.  Prospective studies using standardized psychometric tests are 
scarce and results are difficult to compare (Boivin and Takefman 1995; 
Demyttenaere et al.1992, 1998;  Merari et al. 1992; Thiering et al. 1993). The 
somewhat inconsistent findings in these studies may be due to population 
characteristics, the design of the study, or small sample sizes. Moreover, multi-
centre studies are preferable because predictions have the tendency to be centre-
specific.  
It still has to be established what the role of psychological factors in IVF/ICSI 
outcome is. As this knowledge is a prerequisite for adjuvant psychological 
interventions, the question has a major clinical relevance.  
Several statistical models have been published using combinations of biomedical 
factors in relation with IVF outcome. The model of Templeton is well known; it is 
based on a large database and includes the factors age, duration of infertility, 
number of previous unsuccessful IVF attempts, tubal indication for fertility 
treatment and number of previous pregnancies as independent predictors 
(Templeton et al.1996). Stolwijk et al. (1996) identified two factors, i.e. at least two 
preceding gestations and age, to be significant in predicting IVF-outcome. It was 
also demonstrated that both models have limited external validity (Stolwijk et al. 
1996; Smeenk et al. 2000). A possible reason for the limited validity of the 
presented models is that they are only based on stable variables. Some studies, 
however, indicate that the success of assisted reproductive techniques (ART) 
treatment may also be dependent on variable factors, such as a woman’s distress 
level at the time of treatment (i.e. Boivin & Takefman 1995; Demyttenaere et al. 
1998; Fachinetti et al. 1997). The main objective of the present study at three 
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Dutch hospitals was to clarify the additional role of pre-existing anxiety and 
depression on IVF/ICSI results, controlling for known predictors.  
 
Materials and Methods 
All patients who went to the University Medical Centre St. Radboud Nijmegen, an 
academic tertiary referral centre in the east of the Netherlands and to two hospitals 
of Breda (Baronie and St. Ignatius), secondary referral hospitals in the south-west 
of the Netherlands, for the first cycle of a new IVF/ICSI treatment between January 
1999 and March 2000, were invited to participate in the study. A long protocol with 
Decapeptyl® (Ferring, Hoofddorp, the Netherlands), Puregon® (Organon, Oss, the 
Netherlands) and Pregnyl® (Organon, Oss, the Netherlands) was used. Only first 
treatment cycles of a three-cycle course of IVF/ICSI were included. A maximum of 
two embryos was transferred per treatment cycle, three days after ovum pick up 
(OPU). Remaining embryos of good quality were cryopreserved. Between cycleday 10 
and 20 of the cycle before the stimulation cycle, so before the start of GnRH-
analogue medication, women were asked to complete questionnaires on 
psychological factors and return it in a pre-paid envelope to the hospital. All 
participants were guaranteed of anonymity and a separation of questionnaire 
information and their clinical management. Signed informed consent was obtained 
from all participants. The study was approved by the Ethical Committees of the 
hospitals in Nijmegen and Breda. 
 
Of the 359 invited patients (313 in Nijmegen, 46 in Breda), 68 declined or were 
excluded. Reasons indicated by patients were: lack of time (twenty-three), already 
participating in another study (seven), emotional burden of the treatment (seven), 
unknown (five). Twelve patients were excluded because of missing data and 
fourteen because of language difficulties. Therefore, the remaining group consisted 
of 291 (81%) patients.  
 
The demographic and gynaecological variables studied are derived from the model 
of Templeton; age, duration of infertility, number of previous pregnancies and 
infertility diagnosis. In addition to ‘tubal’ factor as diagnosis as in Templeton’s 
model, other infertility diagnoses were included. Since only the first cycle of each 
patient was included, number of previous unsuccessful IVF-attempts was not 
included as a predictor. 
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Anxiety was measured by means of the Dutch version of the State and Trait Anxiety 
Inventory (STAI; Spielberger, 1970; Dutch version by: VanderPloeg et al. 1980), a 
scale showing satisfactory reliability and validity. Trait anxiety refers to a general 
tendency of an individual to be anxious, whereas state anxiety refers to the anxiety 
level of an individual at a given moment. Both measures include 20 items, the score 
for each item ranging from 1-4, higher scores indicating more anxiety. Total scores 
range from 20 to 80. Coefficient alpha for state anxiety in our sample was 0.94 and 
for trait anxiety 0.91. 
Depression was measured by means of the Dutch version of the Beck Depression 
Inventory (BDI), (Beck et al. 1976; Dutch version by: Bouman et al. 1985) being one 
of the most widely used instruments for assessing intensity of depression and for 
detecting depression in the general population.  This reliable and valid measure 
(Beck et al. 1988) includes 21 items, the score for each item ranging from 0 (low) to 
3 (high). Total scores range from 0 to 63. Coefficient alpha in our sample was 0.86. 
Because of high levels of curtosis and skewness on the BDI scale, square roots were 
taken from the scores and used in the analysis (Tabachnick et al. 1996). 
 
The outcome measures were the number of follicles, number of embryos and 
pregnancy status. The number of follicles was defined as the number of follicles ( 
9mm) present on trans-vaginal-ultrasound, on the day of human chorionic 
gonadotropin (HCG) administration. Pregnancy was defined as a positive urinary 
pregnancy test 15 days after embryo transfer. In our analysis we focussed on the 
women who reached embryo transfer because we wanted to be able to compare all 
stages of treatment, including the implantation phase. 
 
All statistical analyses were performed by means of the SPSS-program. Multiple 
logistic regression analysis was used to analyse the variables related to pregnancy. 
The first step was, by using a backward conditional stepwise procedure, to find 
biomedical variables from Templeton’s model related to treatment outcome in our 
sample. The second step was to add psychological variables to this block of 
variables, again in a stepwise backward procedure. Linear logistic regression 
techniques were used to compare outcome variables between groups and T-tests 
were used to compare groups on baseline parameters. 
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Results 
The patients (n=291) categorised the cause of infertility themselves as follows: 
female factor 25%, male factor 42%, combined male and female 9% and idiopathic 
24 %. Thirty-six percent (n=85) of the cycles, diagnosed as ‘male factor only’, were 
ICSI cycles. Thirty-five percent reported one or more previous pregnancies, 19% 
reported one or more previous abortions and 26% reported one or more previous 
live births, of which nine percent resulted from a previous IVF/ICSI attempt. The 
state-anxiety (t=.52, p=.61) and the BDI-depression scores (t=1.40, p=.16) did not 
differ between Nijmegen and Breda. The trait anxiety, however, was significantly 
lower in Breda (t=2.10, p=.04). The state and trait anxiety levels, as well as the 
depression level of our IVF/ICSI population lie within the normal range, as 
compared with a community sample, which is consistent with previous publications 
(Freeman et al. 1985; Hearn et al. 1987; Reading et al. 1989). 
From the original group of 291 women, 237 (81%) women reached embryotransfer. 
Reasons for not reaching embryotransfer were cancellation by patient (n=4), poor 
response (n=19), risk of ovarian hyperstimulation syndrome (n=5) or total 
fertilization failure (n=26). The group who did not reach embryotransfer (N=54) was 
the same age (t=.97, p=.34) as the group who did reach embryotransfer.  In addition 
no differences in state anxiety (t=.59, p=.56), trait anxiety (t=.14, p=.89) and 
depression (t=1.38, p=.17) scores were found. Sample characteristics with respect to 
demographic and psychological variables of the group that reached embryotransfer 
are shown in Table I.  
 
Table I: Characteristics of the group women who reached ET  (N=237) 
 
 Mean SD Range Median 
Age (years) 33.4 3.7 24-42 33 
Duration of infertility (years) 3.7 2.0 1-13 3 
State anxiety score 37.3 9.6 20-74 36 
Trait anxiety score 36.8 8.3 20-63 35 
BDI score 5.6 5.1 0-20 4 
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The regression analysis with only biomedical variables shows that higher age and 
lower number of previous pregnancies were correlated with poor outcome (Table II). 
Duration of infertility and the diagnostic category were excluded from the equation 
due to a lack of correlation with pregnancy in the analysis.  
 
Table II:  The logistic regression model with biomedical variables 
 
Variable B Wald Statistic P value 95% CI 
Age -0.10 5.66 .02 (-.17, -.02) 
Previous Pregnancy 0.55 4.10 .04 (.02, 1.08) 
Constant 2.72 4.04 .04  
 
Model characteristics: 
-2 Log Likelihood  = 289,8 
Goodness of Fit  = 221,0 
R2    = .04 
Chi-Square 7.4 ;  p-value = .02 
 
Variables not in the equation with p-values between brackets. [Residual Chi Square 
3.4, p=.64]  
Duration of Infertility (.77), diagnosis: female factor (.67), diagnosis: male factor 
(.22), diagnosis: combined female/male (.70), diagnosis: unknown (.14) 
 
In Table III the model is depicted after adding psychological factors to the model 
with the two biomedical variables. The trait anxiety score and the depression score 
were left out from the equation due to a lack of correlation with pregnancy in the 
analysis. 
 
Table III:  Logistic model with biomedical variables and psychological variables 
 
Variable B Wald Statistic P value 95%CI 
Age -0.12 7.65 .01 (-.21, -.03) 
Previous Pregnancy 0.66 5.40 .02 (.10, 1.21) 
State anxiety -0.04 5.99 .01 (-.06, -.01) 
Constant 4.84 9.35 .002  
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Model characteristics: 
-2 Log Likelihood  = 278.8 
Goodness of Fit       =  219.5 
R2             =  .10 
Chi-Square 16.34 ; p =  .001 
Variables not in the equation with p-values between brackets. [Residual Chi Square 
1.5, p= .48] 
BDI (.23), Trait anxiety (.62) 
 
The model showed a significant independent negative relation of state anxiety with 
pregnancy. The variable depression did not enter the model because it had a high 
correlation anxiety (r=0.70) with state anxiety. In a model with age, number of 
previous pregnancies and depression only, depression proved to have an 
independent and significant negative correlation with pregnancy (p=.03) as well. 
Therefore, we repeated the analysis using the ‘composite’ score, in which the 
standardised scores of state anxiety and depression were summed. The results of 
this final model are depicted in Table IV.   
 
Table IV: Logistic model with biomedical variables and the composite score of state 
anxiety and depression  
 
Variable B Wald Statistic P value 95%CI 
Age -0.12 6.30 .01 (-.21, -.03) 
Previous Pregnancy 0.82 7.19 .01 (.10, 1.21) 
Composite score -0.17 7.66 .01 (-.26, -.05) 
Constant 3.27 4.74 .03  
 
Model characteristics: 
-2 Log Likelihood   =  245.1 
Goodness of Fit       =  196.7 
R2              =  0.12 
Chi-Square 18.53 ; Significance .003 
 
To look for the stage of treatment in which the effect of state anxiety on treatment 
outcome is most obvious, we compared the outcome variables of various stages 
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during treatment. Linear regression revealed no relation of age, number of previous 
pregnancies and state anxiety with the number of the follicles (b=-.14, p=.14; b= -
.05, p=.49; b=-.06, p=..37 respectively), oocytes (b=-.12, p=.09 ; b=-.04, p=.56; b=-
.06 , p=.41), or embryos (b=-.14, p=.06; b=.06, p=.37; b=-.02, p=.75). Our data show 
that the stimulation and the fertilisation phase were not influenced, whereas the 
pregnancy rate was influenced. 
 
Discussion 
This study showed a significant relation of psychological variables with pregnancy 
in IVF/ICSI-treatment. Adding the composite score of state anxiety and depression 
to the model improved the model significantly and led to the best prognostic model 
with respect to pregnancy. The analysis showed that state anxiety only is a better 
predictor of pregnancy than depression. 
In addition we found an independent relation of ‘age’ and ‘number of previous 
pregnancies’ with the probability to become pregnant, which is consistent with 
previous findings (Stolwijk et al. 1996). Other variables presented in the model by 
Templeton et al. (1996) did not show a significant relation with treatment outcome, 
stressing once more the limited external validity of the Templeton model.  Our data 
are in line with a study by Fachinetti et al. (1997) in which effects of state anxiety 
and not trait anxiety on ART outcome were found. Demyttenaere et al. (1992) also 
found a negative influence of state anxiety on IVF outcome, but did not publish on 
trait anxiety.  
Thiering et al. (1993) found significantly lower success rates in IVF in depressed 
versus non-depressed women, but could not demonstrate a predictive value of the 
anxiety. Several authors, however, found no relation between the emotional status 
of women and the outcome of ART treatment (Ardenti et al. 1999; Boivin & 
Takefman 1995; Harlow et al. 1996; Slade et al. 1997).  
Though the power of our study was good and the study was multicentred in design, 
it would be recommendable to reproduce the findings in a larger group and validate 
the model in another population. Moreover, as the number of co-variables is limited 
to those found in the Templeton model and the fact that logistic regression cannot 
establish the exact relationship among variables, causal inference should be made 
cautiously. Finally we cannot exclude the possibility of selection bias, as some 
patients indicated ‘stress’ as a reason not to participate. 
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The mechanism of the distress effect on pregnancy rates is still unknown. Subtle 
disturbances of the cycle may play a role, which are caused by subtle 
endocrinological alterations (Psech et al. 1989;  Demyttenaere et al. 1989, 1994). In 
a prospective study in women undergoing IVF an increase during treatment in state 
anxiety was established, parallel to increases in serum prolactin and cortisol 
(Harlow et al. 1996). Depression was found to be associated with an abnormal 
regulation of luteinizing hormone (Meller et al. 1997). 
Some studies suggest promising results of psychological interventions on pregnancy 
rates (Domar et al. 1990, 2000; Sarrel & DeCherney 1985). Further prospective 
research is needed to obtain a better understanding of the mechanisms involved 
and provide an evidence base for effective stress reduction interventions aiming at 
better pregnancy rates.  
In conclusion, our study shows that state anxiety may have an independent 
contribution to explaining the variability in pregnancy rates in addition to some well 
known biomedical variables. This effect is probably strongest in the implantation 
phase of the cycle. These findings are particularly important because in contrast to, 
for example, the factor age, psychological factors may be well sensitive to 
interventions, thus increasing the chance of improving treatment results.  In view of 
our results, psychological factors should be taken in consideration in patient 
counseling. 
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Abstract 
 
Objective: The aim of the present study was to gain more insight into psychological 
aspects of dropping out in IVF/ICSI. 
Design: Prospective cohort study. 
Setting: University hospital-based tertiary care fertility clinic. 
Patient(s): Women entering their first treatment cycle of IVF or ICSI. 
Intervention(s): Standardized psychological questionnaires were administered before 
the start of the treatment and after treatment. 
Main Outcome Measure(s): Reasons for dropout, state and trait anxiety, depression, 
marital and sexual satisfaction 
Result(s): Base-line psychological factors and the probability of dropout after 
IVF/ICSI treatment were found to be associated in the group that stopped 
treatment for psychological reasons. Those who were denied further treatment by 
the medical team, the ‘actively censored’ group, did not show pretreatment 
differences regarding psychological measures in comparison with those who 
continued treatment. After treatment, the group that was denied further treatment 
showed higher levels of anxiety and depression compared to those that continued.  
Conclusion(s): Dropout, being a well-known phenomenon in IVF/ICSI, is related to 
pre-existing psychological factors in IVF/ICSI. Actively censored patients were 
psychologically well adjusted before treatment, but this changed after censoring.  
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Introduction 
High dropout rates are a common phenomenon in IVF/ICSI treatment (De Vries et 
al. 1999, Land et al. 1997, Osmanagaoglu et al. 1999, Roest J et al. 1998, Stolwijk 
et al. 2000, Goverde et al. 2000, Emery et al. 1997). Dropout may be considered as 
an adverse treatment outcome. The prognosis of a couple and thereby the 
effectiveness of the program, in terms of cumulative pregnancy rates, is strongly 
influenced by selective early cessation. Discontinuation of treatment may have 
various reasons and dropouts can be categorized as ‘actively’ and ‘passively’ 
censored (Land et al. 1997). ‘Actively censored’ patients are those who are denied 
further treatment because of a poor prognosis (physician recommended dropout). 
‘Passively censored’ patients are those who discontinued treatment voluntarily.  
Reasons for dropout have been scarcely investigated until now. However, in 
retrospective studies several reasons were identified; psychological, financial, 
relational and practical reasons, but also denial of further treatment, other medical 
problems, other treatment options, fears regarding the complications of the 
procedure and treatment-independent pregnancy (Land et al. 1997, Osmanagaoglu 
et al. 1999). Emotional stress was already found to be the second (after financial) 
most influential factor leading to the couple’s decision not to pursue treatment 
(Goldfarb et al. 1997). The age of the husband and being a mother or not were 
found to related to the decision to continue treatment or not. But age of the woman, 
duration of infertility and number of IVF attempts were not found to be related to 
the decision (Callan et al. 1988). 
The aim of the present study was to gain more insight into the psychological and 
biomedical considerations for dropping out in IVF/ICSI in a prospective manner. We 
hypothesized that (I) pretreatment psychological and marital and sexual aspects 
play an important role in couples who are passively censored, (II) actively censored 
patients show increased levels of anxiety and depression after censoring after 
controlling for treatment outcome. As a result, we might be able to early identify the 
couples prone to drop out or at risk for developing psychological problems.  
 
Materials and Methods 
  
Sample 
Data were used from couples who came for the first cycle of a new IVF/ICSI 
treatment, at the University Medical Centre Nijmegen, The Netherlands, between 
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January 1999 and May 2000. This group participated in a prospective follow-up 
study on the psychological aspects of IVF/ICSI treatment. Details of the program 
and the applied protocol were described previously (10). Four-hundred-and-fifty 
couples were contacted and 380 (84%) were willing to participate. Participants were 
asked to complete questionnaires on psychological factors two weeks before the 
start of treatment (T1) and four weeks after the first treatment cycle (T2), once the 
pregnancy test result was known.  
All participants were guaranteed confidentiality and a separation of the 
questionnaire information on psychological, marital and sexual factors and their 
clinical management. Written informed consent was obtained from all participants. 
Couples were included in the study as soon as they were called on to start the first 
treatment cycle. They were observed until an ongoing pregnancy was determined, or 
discontinued treatment. The follow up period was at least 12 months after the first 
and (if applicable) after the second completed IVF/ICSI cycle. Dropouts were defined 
as the group of patients who stopped treatment after an IVF/ICSI cycle, in which 
they failed to achieve an ongoing pregnancy. In order to actualize the waiting list, 
patients who failed to contact the team for more than 12 months after a failed cycle 
were contacted to determine whether they had withdrawn from treatment. Reasons 
for withdrawal were recorded. If patients indicated that they wanted to stay on the 
waiting list, they were classified as having postponed treatment. Patients who could 
not be contacted, for instance after moving without giving notice, were considered 
lost for follow up. 
An ongoing pregnancy was defined as a positive heartbeat on transvaginal 
ultrasound, five weeks after embryo transfer. If a woman would turn out not to be 
pregnant, the cryopreseration-thaw cycles, if applicable, were being done directly 
after the treatment cycle in which the embryos were obtained. An attempt was 
therefore defined as the initial cycle and the cryopreservation-thaw cycle(s) resulting 
from this cycle. The pregnancies resulting from cryopreservation-thaw cycles were 
included in the overall pregnancy results. 
A maximum of three completed attempts was included in the study. Since health 
insurance institutions in the Netherlands compensate three IVF/ICSI attempts, 
financial reasons for dropout could be excluded. Poor prognosis as the reason for 
active censoring was defined as poor response to high dosages of recombinant FSH 
(< 4 oocytes) and poor fertilisation (< 5% of the oocytes fertilized by ICSI in the case 
of  4 oocytes) (Smeenk et al. 2001). 
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In case of passive censoring, the patients indicated their main motives for 
discontinuation during a visit at our outpatient ward to evaluate the preceding 
treatment cycle. Sometimes, patients only informed the team by phone of their 
decision. The reasons for discontinuation were categorized based upon the couple’s 
motives and the interpretation of the consult at the outpatient ward by the 
physician. This was documented in the medical file. 
If an IVF/ICSI attempt was converted to an intra-uterine insemination (IUI) due to 
poor response, or stopped due to complaints of the ovarian hyperstimulation 
syndrome (OHSS), the IVF/ICSI attempt was considered to have failed.  
Pregnancies that did not result from an IVF/ICSI attempt were classified in the 
passively censored group, which included pregnancies resulting from an IUI 
procedure. 
 
Psychological measures 
Anxiety was measured by means of the Dutch version of the State and Trait Anxiety 
Inventory (Spielberger et al. 1970), a scale showing satisfactory reliability and 
validity. Trait anxiety refers to a general tendency of an individual to be anxious, 
whereas state anxiety refers to the anxiety level of an individual at a given moment. 
Both measures include 20 items, the score for each item ranging from 1 to 4, with 
higher scores indicating greater anxiety. Therefore the total scores range from 20 to 
80. 
Depression was measured by means of the Dutch version of the Beck Depression 
Inventory (BDI) (Beck and Beamesderfer 1976). This scale is one of the most widely 
used, reliable and valid instruments for assessing intensity of depression and for 
detecting depression in the general population. This measure includes 21 items, the 
scores for each item ranging from 0 (low) to 3 (high), therefore the total scores range 
from 0 to 63. Square roots were taken from the scores to obtain a normal 
distribution. 
Relational aspects were measured by means of two scales of the Maudsley Marital 
Questionnaire (MMQ). The scores can be reduced to: a scale to assess relational (10 
items, range 0-80) and sexual (dis)satisfaction (5 items, range 0-40) (Spielberger et 
al. 1970). Higher scores indicate greater dissatisfaction (Arrindell et al. 1983).  
 
Demographic factors 
Age and duration of infertility were compared between the groups. 
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Statistical analysis 
All statistical analyses were performed by means of the SPSS-program. One-way 
analysis of variance (ANOVAs) with Dunnett posthoc tests were used to compare 
groups. So the resulting p-values were calculated after Dunnett posthoc tests. 
Kruskal-Wallis tests were used to compare the subgroups in which the reasons for 
passive dropout were compared, since these data were not normally distributed. 
Multiple logistic regression was used to analyze the variables related to dropout. In 
a backward elimination procedure the best predictor with respect to dropout was 
identified.  
 
In view of our hypothesis, patients who discontinued treatment due to passive 
censoring after the first and second cycle were compared with those who continued 
treatment. Furthermore, the patients who stopped treatment due to active 
censoring were also compared with those who continued treatment. The 
pretreatment anxiety and depression, the quality of the relationship with the 
partner and demographic factors were taken into consideration.  
 
Results 
Three-hundred-and-eighty women (84% of all invited women) completed the first set 
of questionnaires (T1). Two-hundred-and-forty out of 380 (63%) completed the 
second set of questionnaires as well (T2). The women underwent a total of 748 
cycles, 62% being IVF and 38% being ICSI cycles. In the first cycle, 28 cycles were 
converted into IUI procedures and four cycles were discontinued because of OHSS.  
 
In the second cycle, 5 cycles were converted into IUI procedures. The majority of the 
women, 60%, reported primary infertility. The cause of infertility was categorized as: 
female only 23%, male only 40%, combined male and female 8% and idiopathic 
29%.  
 
Other baseline characteristics on pretreatment biomedical and psychological 
variables can be found in Table I.  
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Table I: Biomedical and psychological characteristics of the cohort (N=380) 
 
 Mean SD Range Median 
Woman’s age (years) 34.1 3.9 21-43 34 
Duration of infertility (years) 3.7 2.2 1-16 3 
State anxiety score 37.1 10.6 20-74 36 
Trait anxiety score 37.2 8.5 20-63 36 
Depression score 6.2 5.8 0-36 5 
Relational dissatisfaction 9.8 7.3 0-42 8 
Sexual dissatisfaction 7.6 6.1 0-38 6 
 
Treatment characteristics of the cohort can be found in Table II. Four (11%) ongoing 
pregnancies resulting from 36 cryopreservation-thaw cycles were observed in the 
first treatment cycle, no pregnancies were observed in 13 cryo-cycles during the 
second cycle and in the third cycle two (18%) pregnancies was observed in 11 
cryopreservation-thaw cycles.  
 
Table II: Results of the first three IVF/ICSI cycles: pregnancy rates (PR) and 
dropout rates (DR)  
 
 First cycle Second cycle Third cycle 
No.of patients 380 237 135 
No.of pregnancies  92 62 18 
No.of dropouts 
(through censoring) 
16 active (5.6%) 
35 passive (12.2%) 
8 active (4.6%) 
32 passive (18.3%) 
 
PR per cycle  
(95% CI) 
24.2% 
(19.9-28.5) 
26.2% 
(20.6-31.8) 
13.3% 
(7.6-19.0) 
DR per cycle  
(95% CI) 
17.7% 
(13.3-22.1) 
22.8% 
(16.6-29.0) 
 
 
 
Dropout first treatment cycle 
Psychological and demographic variables were compared between the passively and 
the actively censored group, separately, with the uncensored group. Details of these 
groups, regarding the first cycle can be found in Table III.  
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Table III: Comparison of baseline characteristics (mean(SD)) between groups of 
patients who were uncensored, passively censored and actively censored after the 
first treatment cycle 
 
  
Uncensored 
(0) 
Passively 
Censored 
(1) 
Actively 
Censored 
(2) 
Post 
hoc 
tests 
No. of patients 237 35 16  
Woman’s age (years) 33.8 (3.8) 35.4 (3.7) 36.9 (3.7) 0<2; 1=2 
Duration of infertility (years) 3.7 (2.1) 4.1 (2.5) 4.2 (3.7) 0=1=2 
State anxiety score 36.3 (10.0) 42.5 (14.3) 39.7 (12.2) 0<1; 1=2 
Trait anxiety score 37.0 (8.3) 39.6 (10.0) 37.8 (8.3) 0=1=2 
Depression score 5.8 (5.3) 9.5 (8.7) 5.9 (6.0) 0,2<1 
Relational dissatisfaction 9.8 (7.3) 10.5 (7.8) 8.8 (6.0) 0=1=2 
Sexual dissatisfaction 7.7 (6.1) 8.2 (6.8) 6.2 (4.3) 0=1=2 
 
The passively censored group during the first cycle showed higher scores 
pretreatment on depression (p=.00) and state anxiety (p=.00) than the group that 
continued treatment after the first treatment cycle. In the passively censored group 
the differences regarding demographic variables and other psychological measures 
did not differ significantly from those that continued treatment.  
The percentages of the various reasons for passive censoring after the first 
treatment cycle can be found in Table V.   
 
The actively censored group was characterized by higher age (p=.02), the duration of 
infertility did not differ significantly compared with those that continued treatment. 
No statistically significant differences regarding psychological, marital and sexual 
variables were found between the actively censored group and the couples who 
continued treatment.  
 
Dropout second treatment cycle 
Again psychological and demographic variables were compared between the 
passively and the actively censored group, separately, with the uncensored group. 
Details of these groups, regarding the second cycle can be found in Table IV.  
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Table IV: Comparison of baseline characteristics (mean(SD)) between groups of 
patients who were uncensored, passively censored and actively censored after the 
second treatment cycle 
 
  
Uncensored 
(0) 
Passively 
Censored 
(1) 
Actively 
Censored 
(2) 
Post 
hoc 
tests 
No. of patients 135 32 8  
Woman’s age (years) 34.0 (4.0) 33.9 (4.0) 35.9 (3.6) 0=1=2 
Duration of infertility (years) 3.7 (2.1) 4.1 (2.5) 4.2 (3.7) 0=1=2 
State anxiety score 38.6 (10.3) 38.0 (12.4) 34.2 (11.9) 0=1=2 
Depression score 6.9 (6.0) 5.3 (5.6) 5.8 (3.8) 0=1=2 
Marital dissatisfaction 10.7 (8.2) 8.3 (6.2) 8.2 (6.8) 0=1=2 
Sexual dissatisfaction 8.6 (6.4) 5.1 (5.8) 6.7 (5.8) 0=1=2 
 
The passively censored group after the second cycle showed no significant 
differences with the uncensored group regarding any of the measures. The 
percentages of the various reasons for passive censoring after the second treatment 
cycle can be found in Table V 
 
Table V: Reasons for passive censoring after the first and the second cycle 
 
Reason for passive censoring Dropout first cycle Dropout second cycle 
Psychological reasons N=10 (29%) N=7 (22%) 
Other medical treatment N=1  (3%) N=6 (19%) 
IVF/ICSI  independent pregnancy N=9  (26%) N=4 (13%) 
Fear of complications N=9  (26%) N=4 (13%) 
Postponement/unknown N=6  (17%) N=11 (34%) 
 
The actively censored group after the second cycle showed no statistically 
significant differences with the group that continued regarding age and duration of 
infertility. Lower scores were found on trait anxiety in the group that was actively 
censored (p=.04), but other measures did not differ significantly.  
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Analyses of subgroups  
In order to obtain sufficient sample sizes, the subgroups who indicated the reason 
for passive dropout after the first and second cycle (in Table V) were combined. The 
subgroups were compared against each other on all psychological factors.  
No statistically significant differences were observed in comparing the subgroups. 
Although the group that indicated psychological reasons to quit treatment (n=17) 
and the group that indicated fear of complications (n=13) showed the highest levels 
of anxiety and depression and the highest scores on the scales for marital and 
sexual dissatisfaction before treatment, these differences did not reach statistically 
significance.  
 
Measurement at T2: after the first treatment 
The results from the uncensored, censored active and the censored passive group 
with regard to anxiety and depression are depicted in figure I and II. Note that in 
the repeated measures design only complete data sets could be included. A 
significant group x time effect on depression (F=3.56; p=.03), but not on anxiety 
(F=1.35; p=.26) was found.  
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Figure I : Time effect of anxiety by way of censoring 
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In the figures I and II the significant increase in depression in the actively censored 
group is clearly shown. Unfortunately, a high refusal rate for ongoing participation 
in the study (50%) was found in this group.  
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Figure II: Time effect of depression by way of censoring 
 
 
Other increments in anxiety and depression in the various groups did not reach 
statistical significance. No significant differences could be found on marital and 
sexual aspects.  
 
Clinical implications 
In order to find the factor that was strongest correlated with passively censored 
dropout, a logistic regression of all available biomedical and psychological variables 
in a stepwise backward procedure was done. This revealed that pretreatment 
depression showed the strongest association with passively censored dropout 
(Chi=8.6, Beta=.085, Wald=8.60, p=.003).  
The clinical implications were researched by dichotomizing the cohort in a group 
with scores indicative of moderate or severe depression (BDI  16) and a group with 
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BDI scores indicating mild or no depression (BDI<16) (Beck and Beamesderfer 
1976). Based upon this dichotomisation a pretreatment ‘depressed’ group was 
identified in our sample (n=28). In this group a cumulative dropout rate of 35.7% 
was observed after three cycles. 29% of the depressed group (n=8) dropped out for 
psychological reasons.  
 
Discussion 
In this study we showed that passive dropout rates were related to psychological 
factors. Furthermore, we showed that marital and sexual aspects did not play an 
important role in passively censored couples. Actively censored patients were found 
to be significantly more distressed after the treatment than uncensored and 
passively censored women. 
Dropout could not always be considered as an adverse treatment outcome, since 
26% of the passively censored women reported a treatment-independent pregnancy 
after the first treatment cycle and 13% after the second treatment cycle. One could 
argue whether pregnancies that resulted from IUI cycles, after they were converted 
from IVF cycles, should be part of the passively censored group. Only a few 
pregnancies resulted from the IUI procedure, so the message remains that 
treatment independent pregnancies accounted for a considerable percentage of 
passively censored dropout.  
Evers et al. (1998) reported on spontaneous pregnancies, especially occurring 
during the first three months on the waiting list for IVF/ICSI. It was suggested that 
this might be attributed to stress relief. In line with this hypothesis, initial 
treatment could have had the same beneficial effect and therefore be the 
explanation for the treatment-independent pregnancy rate in our sample.  
The dropout group was a heterogeneous population, in which a clear distinction 
had to be made between the actively and the passively censored group. In our 
sample approximately 5% was actively censored per cycle due to poor response or 
poor fertilization during the treatment cycle. The actively censored group was 
characterized by higher age, however, not by a longer duration of infertility. The 
actively censored group did not differ psychologically from the uncensored group, 
although this changed after treatment. We found that active censoring led to 
significantly higher levels of depression.  
This increase, but also the increase in anxiety, was particularly striking when 
compared with the uncensored and the passively censored group after an 
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unsuccessful treatment cycle. The actively censored group could therefore most 
likely benefit from psychological support in dealing with the outcome of treatment. 
The findings have to be interpreted carefully, since especially in the actively 
censored group, a high refusal rate for ongoing participation was observed. On the 
other hand, our findings could even underestimate the effect, since this refusal rate 
for ongoing participation could also be associated with higher levels of anxiety and 
depression. 
In general, anxiety and depression were found to be increased after the first failed 
treatment (Sarrel et al. 1985). The passively censored group was characterized by 
higher scores on depression and state anxiety after the first cycle. No significant 
differences were found on other psychological measures and biomedical variables. 
This group showed no differences regarding any of the measures with the 
uncensored and actively censored group after the second cycle. Poor prognosis in 
terms of a different biomedical profile therefore did not seem to play an important 
role as a reason for dropout after the first or second treatment cycle. The findings 
suggest that the dropout group after the first cycle differed from the dropout group 
after the second cycle. Furthermore, we observed that the percentage of passively 
censored dropouts relatively increased with increasing cycle number. 
No statistically significant differences were observed in comparing the subgroups of 
passively dropouts. Improved information could help especially these couples to 
develop realistic expectations and increase their ability to cope with the treatment.  
For statistical reasons the dropout groups of the first and second cycle had to be 
combined. This limitation of the study could have masked the differences between 
the subgroups during the cycles. In the subset of the passively censored group after 
the first cycle that indicated psychological reasons for dropout we observed high 
levels of anxiety and depression. After the second cycle this could not be observed, 
which could be indicative of a selection process during the first treatment cycle. 
Once again this observation was based on small numbers, so careful interpretation 
is needed. 
Another limitation of the study was that after the second cycle a large subgroup 
(34%) postponed treatment or was lost for follow up. Postponement of the last 
(financially compensated) cycle is a known phenomenon (Emery et al. 1997). Lost 
for follow up is more speculative; it could be due to logistical problems, but also 
intended by the couple. 
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Measures on marital and sexual aspects did not show significant differences 
between groups. This could be due to the fact that they did not play an important 
role in dropout. Whereas clinical experience seems to indicate that patients 
reporting psychological reasons for dropout, also reported difficulties in the 
relationship.  
Previous research showed that a group of couples that did not pursue treatment felt 
that organized support groups could have been helpful to make IVF better or easier 
(Callan et al. 1988). Couples that dropped out due to passive and active censoring 
may benefit from psychological interventions in dealing with failed treatment. 
Moreover, since anxiety and depression were found to be negatively related to 
ongoing pregnancy rates in in-vitro fertilization (Smeenk et al. 2001), the overall 
prognosis of anxious and depressed women in the pretreatment phase could be 
defined as poor. Therefore, the pretreatment clinically depressed group could 
benefit most from psychological interventions from both a prognostic as a 
supportive point of view. 
 
The decision to drop out of treatment is not easy to make for patients as well as for 
clinicians, and therefore the result of careful consideration. Clinicians can obviously 
hide behind protocols specific to their center or practical guidelines, whereas 
patients have to weigh their own pros and cons. Voluntary dropout may even be 
considered as a self-protective measure and from this point of view it is 
questionable whether we should try to prevent it. However, we believe that the 
couple’s ability to face further treatment could be increased and as a result dropout 
rates could be decreased as a result from psychological interventions during 
treatment. Additionally, we believe that a substantial proportion of the passively 
censored couples could benefit from psychological interventions to cope more 
adequately with the failed treatment. Promising results of psychological 
interventions on pregnancy rates have been published (Domar et al. 2000, Boivin et 
al. 2003). Unfortunately, to our knowledge the effect of psychological interventions 
on dropout rates has not been studied. Further research on this particular aspect is 
needed to evaluate the clinical implications of our findings. 
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Abstract 
 
Background: The aim of this study was to examine the associations between the 
stress hormones adrenaline, noradrenaline and cortisol in urine during treatment 
with the self reported stress, in order to investigate the mechanism for the 
previously observed negative association of anxiety and depression with the 
outcome of IVF/ICSI.  
Methods: In a multicentre prospective cohort study, women entering their first cycle 
of IVF/ICSI treatment were asked to participate. From each participant three 
nocturnal urine samples were collected; pre-treatment, before ovum-pickup (OPU) 
and before embryo-transfer (ET) to assess hormonal concentrations. Additionally, 
two questionnaires were administered before the start of the treatment to measure 
anxiety and depression. 
Result(s): 168 women completed the questionnaires and collected at least two urine 
specimens. A significant positive correlation between urinary adrenaline 
concentrations at baseline and ET and the scores on depression at baseline were 
found. In women with successful treatment lower concentrations of adrenaline at 
OPU and lower concentrations of adrenaline and noradrenaline at ET, compared 
with unsuccessful women, were found. 
Conclusion(s): The significant positive association of adrenaline concentration with 
pregnancy and with depression, suggested that this adrenal hormone could be one 
of the links in the complex relationship between psychosocial stress and outcome 
after IVF/ICSI.  
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Introduction 
In vitro fertilization (IVF)/Intra cytoplasmatic sperm injection (ICSI) is a stressful 
experience and its outcome may be influenced by many known and still unknown 
factors. In addition to biomedical factors (such as age and history of pregnancy), 
there is increasing evidence that psychological factors, for instance anxiety and 
depression, are also related to IVF/ICSI treatment outcome (Demyttenaere et al. 
1998; Smeenk et al. 2001). However, there are also studies in which no relationship 
between the psychosocial status of women and treatment outcome has been found 
(Boivin and Takefman, 1995; Slade et al. 1997). This discrepancy may be explained 
by differences in population characteristics, study design and differences in the 
assessment of psychosocial factors.  
In general, a distinction is made between direct and indirect effects of stress. The 
direct effects refer to the effects mediated by the autonomic nervous system, the 
(neuro) endocrine system and the immune system, whereas the indirect effects 
imply those health changes resulting from changes in health behaviour, for 
instance smoking. Modulation results in an integrated adaptive psychobiological 
reaction pattern to environmental challenges (Vingerhoets and Perski, 2000).  
Although the effects of psychosocial stressors on the activity of the sympathetic 
medullar system and on the hypothalamic-pituitary adrenal axis have been studied 
intensively (Sanders and Bruce, 1997; Gold et al. 2003; Schommer et al. 2003; 
Woods et al. 1998), no clear picture emerges on the exact relationship between the 
different types of stressors and release of stress hormones. Moreover, several 
authors reported low correlation coefficients between questionnaire based and 
hormonal indicators of stress (Sanders and Bruce, 1997; Woods et al. 1998).  
 
So far, several reviews on stress and female reproduction have been published (e.g. 
Dobson et al. 2003; Ferin 1999; Greil 1997; Magiakou et al. 1997), but little is 
known about the relationship between psychosocial stress and the release of 
adrenal hormones in relation to IVF/ICSI treatment outcome. As the treatment 
itself most probably influences psychosocial factors, it is extremely difficult to 
separate cause and effect of psychosocial factors on the outcome in IVF (Boivin and 
Takefman, 1995). The complex relationship is mediated by an interplay of various 
systems, the underlying mechanisms of the relationship remain obscure so far. 
Even aspects of the treatment could influence the hormonal response. For instance 
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Luppa et al. (1995) found an increased urinary excretion of cortisol metabolites 
after stimulation with an GnRH agonist.  
In an earlier study we demonstrated that pre-treatment levels of anxiety and 
depression are significantly positively related to treatment outcome in IVF/ICSI 
(Smeenk et al. 2001).  
We hypothesized therefore that pre-treatment levels of anxiety and depression could 
be reflected in higher concentrations of the stress hormones cortisol and 
catecholamines during treatment, which in turn could influence treatment 
outcome. 
The aim of the present study was therefore to examine the association between the 
concentrations of the stress hormones during treatment and the self-reported stress 
in order to investigate the mechanism for the negative effect of anxiety and 
depression on the outcome of IVF/ICSI.  
 
Materials and methods 
Participants 
Patients visiting the outpatient clinic of the department of Obstetrics and 
Gynaecology of the University Medical Centre Nijmegen, an academic tertiary 
referral centre, or visiting the Amphia hospitals in Breda, a secondary referral 
centre, all in the Netherlands, were invited to participate in the study. They were 
scheduled for the first IVF/ICSI treatment cycle between January 1999 and March 
2000. Details of the program and the protocol used have been described previously 
(Smeenk et al. 2001).  
Between day 10 and 20 of the pre-medication cycle, i.e. before the start of GnRH-
analogue administration (day 21), women were asked to complete questionnaires on 
psychological factors. In addition, the women were asked to provide urine samples. 
The first urine sample was obtained before treatment, so before the start of 
medication, at a random convenient day between day 10 and 20 of the pre-
medication cycle. This day was not necessarily the day that the questionnaires were 
being filled out, but in the same period. The other urine samples were taken before 
the time of ovum pick up (OPU) and before the embryo transfer (ET), two stressful 
moments during treatment, as indicated by studies from Merari et al. (1992) and 
Johnston et al. (1987). 
Signed informed consent was obtained from all participants. This study was 
approved by the ethical committees of the institutions. All participants were 
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guaranteed confidentiality, and only the principal investigator (JS) had full access 
to the questionnaires, concentrations of hormones in urine and the clinical data. 
 
Sampling 
Two psychological dimensions of stress were assessed in this study: anxiety and 
depression. Anxiety was measured by means of the Dutch version of the State 
Anxiety Inventory (STAI; Spielberger et al. 1970). Depression was measured using 
the Dutch version of the Beck Depression Inventory (BDI; Beck and Beamesderfer, 
1974). Both questionnaires have shown satisfactory reliability and validity. 
 
For endocrine assessments three nocturnal urine samples were collected. Initially, 
the urine sample was collected in a 2 L polypropylene bottle containing 5 mL of 6 
mol/L hydrochloric acid as preservatives of the catecholamines to prevent 
oxidation, later we used sodium disulfite (Na2S2O5) and Na2EDTA as preservatives to 
enable us to measure cortisol in the same samples. Therefore, in the first 100 of 
urine samples the concentration of cortisol could not be assessed. Consequently, 
the sample sizes for cortisol are smaller than for the catecholamines 
Women were asked to collect all urine after midnight (0.00 hours) including the first 
morning sample, at three timepoints during their treatment cycle: 
  
T1: at baseline (before commencing the IVF/ICSI treatment), 
T2: on the day of OPU, 
T3: on the day of ET.  
 
In the sample adrenaline, noradrenaline and cortisol levels were measured and 
expressed per mmol creatinine to correct for urine sample size.  Urinary creatinine 
concentrations were measured by a modified Jaffé method on a Hitachi 747 
analyzer (Boehringer Mannhein, Germany). 
Levels of adrenaline and noradrenaline were determined by fluorometric 
determination after high performance liquid chromatography (HPLC). In short, 
catecholamines were extracted and subsequently derivatized. The 2,3 diphenyl-
quinoxaline derivatives of adrenaline and noradrenaline were measured (Willemsen 
et al. 1995).  The inter-assay coefficient of variation for the noradrenalin assay 
amounted to 4.2% (n=21) and 5.7% (n=17) at concentrations of 160±6.7 nmol/L 
and 403± 22 nmol/L, respectively. For adrenaline the coefficients of variations were 
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5.7% (n=21) and 6.2%  (n=17) at levels of 63.1 ± 3.6 nmol/L and 67.4 ± 4.2 nmol/L, 
respectively.   
Free cortisol was measured by radioimmunoassay (RIA) after extraction with 
dichloromethane and subsequent paper chromatography, according to the method 
described earlier for cortisol measurement in plasma and saliva (Meulenberg et al. 
1987). To adapt this method for urinary assessment, 3H-cortisol was added as a 
recovery tracer to 0.1 ml of urine, before extraction by means of dichloromethane. 
 
Successful treatment was defined as treatment resulting in a viable pregnancy, with 
a positive heartbeat on transvaginal ultrasound five weeks after ET. 
 
Statistical analysis 
Data analysis was performed by means of the SPSS-program (version 11.0 for 
windows, SPSS inc., Chicago, USA). The Spearman correlation coefficient was used 
to express the association between psychological and hormonal measurements 
(two-tailed).The distribution free Mann-Whitney test for two independent samples 
was used to compare hormonal findings at the various moments during treatment 
between pregnant and non-pregnant women (two-tailed). The nonparametric two-
way ANOVA by ranks, or Friedman test, was used to detect a trend in the hormonal 
response during treatment (two-tailed). 
 
Results 
Two-hundred-forty-six out of 291 participants (85%) returned the questionnaires 
and were willing to collect urine specimens. The remaining 45 patients did not 
participate because of hygienic or logistic reasons.  
Only women of whom questionnaire data and at least two urine specimens (T1 and 
T2) were available, were included in the analysis. A dataset was obtained in 36 
women (66% of the participants) coming from Breda and 132 (69%) coming from 
Nijmegen. The main reason for incomplete data was that a number of women forgot 
to collect the urine the morning before ovum pick-up. The samples of one 
participant were discarded from analysis since the levels of adrenaline and 
noradrenaline at T1 showed extreme variation (>1000%) compared with the levels at 
T2 and T3.  
Unfortunately, the first 100 urine samples were acidified directly after obtaining the 
sample and therefore the concentration of cortisol could not be assessed. 
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Consequently, the sample size for cortisol is smaller than for the catecholamines 
and the sample size varies over the various stages of treatment.  
 
Since no significant differences were found in anxiety (p=.40) and depression 
(p=.29) scores, and between adrenaline (p=.24), noradrenaline (p=.42) and cortisol 
(p=.09) concentrations in urine, between the participants of the two participating 
centres, the statistical analyses were based on the combined dataset of both cities, 
resulting in a sample of 167 women (68% of all participants).  
 
Table I: Demographic and psychological characteristics of the participants (n=168) 
 
Measure Mean SD Range Median 
Age (years) 34.3 3.5 25-42 34 
Duration of Infertility (ys) 3.7 2.1 1-13 3 
State anxiety score 36.6 9.1 20-61 36 
BDI score 5.4 4.7 0-27 5 
 
Table I shows characteristics on demographic and psychological variables of the 
participants.  
 
The ongoing pregnancy rate after the cycle was 32%. During treatment, 16% (n=27) 
of the participants did not reach embryotransfer, due to cancellation by the patient, 
poor response, ovarian hyperstimulation syndrome or total fertilization failure. 
Women who forgot to collect urine samples on T3 did not show statistically 
significant differences on demographic, psychological or outcome variables 
compared with the women did not forget to collect urine.  
 
No statistically significant differences were found between pregnant and non-
pregnant women on age (p=.12), duration of infertility (p=.73), anxiety (p=.28), 
depression (p=.11), but also on the number of follicles (p=.25), number of oocytes 
(p=.45) and number of embryos (p=.07).   
 
 
Chapter 7 
__________________________________________________________________________________________ 
 
 
108 
Table II: Characteristics of the hormonal measures (nmol/mmol creatinin) 
 
Measure n median minimum maximum SD 
Adrenaline T1  167 0.82 0.25 6.49 0.89 
Adrenaline T2 167 0.81 0.18 5.90 0.81 
Adrenaline T3 83 0.72 0.07 4.63 0.84 
Noradrenaline T1 167 15.98 0.97 40.00 6.54 
Noradrenaline T2 167 15.62 0.24 44.87 6.87 
Noradrenaline T3 83 15.52 0.99 40.19 6.67 
Cortisol T1 120 3.50 0.08 30.48 4.24 
Cortisol T2  129 2.92 0.06 12.50 2.96 
Cortisol T3  68 3.18 0.04 36.36 5.45 
 
A large variation between subjects was found for each of the hormones (Table II). 
Table III shows the correlation between the State Anxiety Inventory and the Beck 
Depression Inventory scores and endocrine variables. Depression scores were 
positively associated with concentrations of hormones. In particular, a significant 
positive association was found between adrenaline pre-treatment (.17) and at the 
time of embryo transfer (.25) and the pre-treatment findings on depression. An 
association for anxiety with adrenaline was found as well, although this did not 
reach statistical significance.  
 
Table III: Correlations of questionnaire findings and endocrine measurements 
(nmol/mmol creatinin) Spearman’s rho 
 
 STAI-State BDI score 
Adrenaline T1 .12 (p=.12) .17 (p=.04)* 
Adrenaline T2 .14 (p=.08) .14 (p=.08) 
Adrenaline  T3 .21 (p=.06) .25 (p=.02)* 
Noradrenaline  T1 .06 (p=.56) .09 (p=.28) 
Noradrenaline  T2 .03 (p=.74) .01 (p=.86) 
Noradrenaline  T3 .11 (p=.34) .16 (p=.14) 
Cortisol T1 .06 (p=.52) .13 (p=.16) 
Cortisol T2 .20 (p=.02)* .18 (p=.04)* 
Cortisol T3 -.08 (p=.52) -.10 (p=.42) 
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Furthermore, a significant association was found between cortisol concentrations at 
T2 and the pre-treatment findings on anxiety (.20) and depression (.18). 
Exploratively, these analyses were repeated in subgroups comparing successfully, 
meaning pregnant, or unsuccessfully treated women. The correlation coefficients 
were stable. 
 
Next, hormonal levels between successfully and unsuccessfully treated women were 
compared. The figures show the concentrations of stress hormones during the 
various stages of treatment, in comparing pregnant and non pregnant women.  
 
 
Figure 1: adrenaline/creatinin (nmol/mmol creatinin) during treatment, comparing 
pregnant and non-pregnant women 
 
 
 
 
Box-and-Whisker plots were used to present the data, without displaying the 
outliers, which did not fit the scales of the figures. The outliers were used in the 
statistical analyses.  
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Figure 2:  noradrenaline/creatinin during treatment, comparing pregnant and non-
pregnant women 
 
   a:T1        b:T2     c:T3 
 
 
 
 
 
 
 
 
 
 
Significantly higher levels of adrenaline at the time of ovum pick-up (figure 1b) and 
embryo transfer (figure 1c) and on noradrenaline at the time of embryo transfer 
(figure 2c) were found in unsuccessfully versus successfully treated women. No 
significant hormonal differences were found pre treatment (figure 1a, 2a). In 
addition, no significant differences were found on cortisol (figure 3a, 3b, 3c) . 
 
Figure 3: cortisol/creatinin during treatment, comparing pregnant and non-
pregnant women 
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The concentration of adrenaline showed a downward trend during treatment 
(Chi=10.51; p=.005). In comparing the different stages of treatment, significantly 
lower levels of adrenaline were found at T3 in comparison with T1 (Z=-2.2; p=.03) 
and T2 (Z=-2.5; p=.01).  No significant changes were found for the concentrations of 
noradrenaline (Chi=.68; p=.71) or cortisol (Chi=.56; p=.76) during treatment. No 
significant differences could be observed between unsuccessfully versus 
successfully treated women with regard to the pattern of hormonal response across 
treatment. 
 
Discussion 
The aim of the present study was to investigate the relationship between pre-
treatment psychological findings and stress hormones during IVF/ICSI treatment. 
Additionally, the hormonal levels at various stages of treatment were compared 
between successfully and unsuccessfully treated women. Furthermore, the 
hormonal response during treatment was assessed.  
A positive association between adrenaline levels during treatment and scores on 
pre-treatment depression was found. A similar, although not significant, association 
was found between adrenaline and pre-treatment anxiety. Cortisol levels at the time 
of OPU were found to be associated with pre-treatment anxiety and depression 
scores, whereas no associations were found for noradrenaline. The correlation 
coefficients between questionnaire based and hormonal indicators of stress are 
comparable with those reported in previous publications (Sanders and Bruce, 1997; 
Woods et al. 1998). 
There was a considerable inter-individual variation in baseline values of the 
hormones in this study. In a previous study similar high variation in hormones 
were found and these could not be explained by menstrual cycle, behavioural, 
emotional or cognitive stress reactions (Hansen et al. 2001).  
Overall, the concentration of adrenaline at the time of ET was found to be 
significantly lower than the concentrations of adrenaline at the time of OPU or at 
baseline. A remarkable finding in our study was that successful treatment was 
associated with significantly lower levels of adrenaline at the time of OPU and ET 
and lower levels of noradrenaline at the time of ET. The implantation phase seems 
to be involved, as other treatment variables were not found to differ between the 
outcome groups. Whether the effect of adrenaline is directly or indirectly, however, 
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needs further exploration. To our knowledge, no previous reports on the effect of 
adrenaline on treatment outcome in IVF exist.  
The correlation of adrenaline concentrations with BDI was higher than with STAI. 
This could be due to fact that the chronic nature of the threatening infertility was of 
more importance than the acute state stress, related to the treatment itself. During 
treatment a decrease in the concentration of adrenaline was found, which could be 
explained by high levels of anxiety in anticipation of treatment. No decrease was 
found in the concentrations of the other stress hormones. This finding is in contrast 
with Harlow et al. (1996) who found an increase in cortisol during IVF-treatment. 
However, some of the  differences could be explained by the methodology. As most 
cortisol in blood is bound to a carrier protein, whereas in urine it is unbound, 
assays measuring cortisol in blood and urine are not necessarily measuring the 
same thing. 
 
In our study the stress response during treatment did not differ between women 
who became pregnant after treatment and those who did not become pregnant. This 
finding suggests that the response itself cannot account for the observed difference 
in treatment outcome. Furthermore, in this sample no differences were observed on 
pre-treatment psychological measures between the two outcome groups, possibly 
due to the smaller sample size. 
 
Although the relationship between psychosocial stress and infertility has been 
studied intensively, so far little is known about the effects of catecholamines and 
cortisol on physiological processes involved in reproduction.  
Studies encompassing both catecholamines and cortisol in this particular field are 
extremely rare. Cortisol was studied far more often over the years, thus resulting in 
more hypotheses. 
Catecholamines may affect fertility by altering uterine blood flow (Schenker et al. 
1992). Cortisol, having immuno-suppressant properties, may affect immunological 
conditions needed for implantation. Furthermore, it was found that cortisol levels in 
follicular fluids in stimulated cycles were correlated with oocyte maturity and in 
vitro fertilizability (Fateh et al. 1989). A direct effect on granulosa cells affecting 
steroidogenesis and an influence on oocyte quality was proposed by Michael and 
Cooke (1994). However, in most studies merely an association is presented, as in 
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our study, since optimal research is hardly possible under ‘in vivo’ circumstances in 
this field. 
Recently, Lewicka et al. (2003) have shown that a higher serum cortisol/follicular 
cortisol ratio was associated with pregnancy. Csemiczky et al. (2000) found that 
infertile women have elevated stress levels in terms of circulating prolactin and 
cortisol levels compared to the fertile controls.  
Stress was previously found to be associated with high amounts of activated T cells 
and reduced implantation rates in IVF-women (Gallinelli et al. 2001). Demyttenaere 
et al. (1992) indicated that women with high anticipatory state anxiety levels and 
high anticipatory cortisol concentrations have lower pregnancy rates in IVF. 
Facchinetti et al. (1997) demonstrated a negative correlation between stress 
susceptibility and outcome of IVF. Furthermore, Demyttenaere et al. (1991) 
suggested that personality dependent stress responses are important for conception 
rates in stimulated cycles. On the other hand women undergoing IVF were found to 
respond biophysically different to psychosocial stressors than controls (Lindheim et 
al. 1995).  
A limitation of the study could be the possibly confounding relation between ovarian 
and stress-hormones. The relation between ovarian hormones and the effect on 
catecholamines and cortisol was only scarcely investigated so far.  
Kerdelhue et al. (1997) concluded that the absence of changes in the activity of the 
corticotrophic axis during the hormonal stimulation of IVF suggests that there was 
no major stress component associated with the stimulation phase, although in this 
study cortisol wasn’t assessed. Luppa et al. (1995) did find an increased urinary 
excretion of cortisol metabolites after stimulation with an GnRH agonist, but only in 
women with polycystic ovarian syndrome, and not in healthy premenopausal 
women. Hirshoren et al. (2002) found that hormonal changes during the normal 
menstrual cycle affect noradrenaline, although the correlations with ovarian 
hormones were very small.  
Sanders and Bruce (1999) concluded after studying hormonal and psychological 
measures of stress, that menstrual cycle quality does not account for the 
association between conception with more favourable moods.  
Ferin (1999) stated in a review on stress and the reproductive cycle that sex 
steroids may interact with both central and peripheral substrates of stress, thereby 
possibly modifying the hypothalamic-pituitary-adrenal axis.  
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Overall, hormonal treatment, and consequently the altered ovarian hormones, 
influence hormonal stress responses. The exact mechanism, however, remains 
unclear. 
 
We conclude that anxiety and especially depression before IVF/ICSI treatment were 
positively associated with urine adrenaline levels during treatment. However, there 
was a large overlap in levels of this hormone between successfully and 
unsuccessfully treated women, which limits the applicability in daily clinical 
practice. A drop in adrenaline concentrations at the time of ET was found. Lower 
concentrations of adrenaline at the time of OPU and ET and lower levels of 
noradrenaline at the time of ET were found in women with successful treatment. 
Adrenaline, therefore, might be an important factor in the complex relationship 
between psychosocial stress and outcome after IVF/ICSI.  
 
We recommend that future studies relating stress to treatment outcome, should 
encompass all known aspects of stress, e.g. psychological aspects, the autonomic 
nervous system and the (neuro) endocrine system. 
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Abstract 
 
Background: A longitudinal study into the course of the emotional response to IVF 
from pre-treatment to six months post-treatment and factors that contributed to 
that course.  
Methods: 148 IVF patients and 71 partners completed self-report questionnaires on 
anxiety, depression, personality characteristics, meaning of fertility problems, 
coping, marital relationship and social support at pre-treatment. Assessments of 
anxiety and depression were repeated immediately following the final treatment 
cycle and again six months later.  
Results: Women showed an increase of both anxiety and depression after 
unsuccessful treatment and a decrease after successful treatment. Men showed no 
change in anxiety and depression neither after successful nor after successful 
treatment. In the six months after unsuccessful treatment, women showed no 
recovery.  At follow-up, more than 20% of the women showed sub-clinical forms of 
anxiety and/or depression. Personality characteristics, meaning of the fertility 
problems, and social support determined the course of the emotional response.  
Conclusions: Most women adjusted well to unsuccessful treatment but at follow-up, 
a considerable part still showed substantial emotional problems. Personality 
characteristics, pre treatment meaning of the fertility problems and social support 
have shown to determine the adjustment to unsuccessful IVF in women. This allows 
early identification of women at risk as well as tailored interventions.  
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Introduction 
Fertility problems consist of both medical and emotional aspects. While the physical 
impact of the medical treatment is considerable (Evers and Te Velde, 1999), couples 
considered emotional aspects more stressful (Kopitzke et al. 1991). For most 
couples, unsuccessful in vitro fertilization (IVF) or intracytoplasmic sperm injection 
(ICSI) treatment means the end of further medical treatment possibilities. This does 
not, however, signal the end of emotional suffering. How do couples adjust 
emotionally to unsuccessful fertility treatment? Despite a great deal of research into 
the emotional aspects of IVF and ICSI treatment, there are still few longitudinal 
studies on emotional adjustment before, between and after different consecutive 
treatment cycles. These types of studies would provide insight into the course and 
intensity of emotional response to treatment. In addition, the study would make it 
possible to identify those factors that contribute to the course of emotional 
adjustment. This would enable couples at risk of developing severe emotional 
problems as a result of one or more unsuccessful treatment cycles to be identified 
in time and offered counselling.  
The stressor of fertility problems comprises various elements: the threat of 
treatment and possible childlessness, uncertainty and uncontrollability of 
treatment outcome, and the loss of hopes of pregnancy and creating a family with 
one or more children (Dunkel-Schetter and Lobel, 1991). Threatening situations 
with much uncertainty about the course they will take can evoke anxiety. A sense of 
loss, and loss of control can evoke feelings of depression. Differentiating between 
anxiety and depression is important because they both require different 
psychosocial interventions (Hawton et al. 1989). 
Previous cross-sectional studies on the course of emotional response to fertility 
problems in general  have compared groups of patients in different phases of 
fertility treatment. These studies revealed curvilinear relationships between length 
of treatment and emotional adjustment in women before they started IVF or ICSI 
treatment with most distress in those with moderate length of treatment compared 
to those with less and more length of treatment (Boivin et al. 1995, Berg and 
Wilson, 1991). After the start of IVF or ICSI, a positive relationship between distress 
and the number of unsuccessful treatment cycles was found (Slade et al. 1997; 
Beaurepaire et al. 1994). After ceasing fertility treatment, however, negative 
emotional response seems to decrease as time passes, indicating that couples seem 
to eventually adjust to their infertility (Daniluk, 2001; Hammarberg et al. 2001; 
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Leiblum et al. 1998; Weaver et al. 1997). However, there is a lack of longitudinal 
studies that supported these findings.  
A few prospective studies have been carried out to predict emotional response to 
fertility treatment (Terry & Hynes, 1998; Litt et al. 1992).  
 
These studies supported the idea that optimism and acceptance of fertility problems 
are protective factors in adjustment to unsuccessful fertility treatment. Both studies 
predicted emotional response to only one treatment cycle and did not differentiate 
between anxiety and depression. 
Next to optimism and acceptance, there are other factors that might predict 
emotional response to unsuccessful fertility treatment. Selection of possible 
predictors can be based on stress vulnerability models (e.g. Holahan et al. 1996; 
Ormel et al. 1991; Costa et al. 1996). Neuroticism, cognitions of helplessness when 
faced with a stressor, avoidant coping and dissatisfaction with the marital and 
sexual relationship are identified as risk factors, while optimism, acceptance of the 
stressor, and the perceived availability of social support are identified as protective 
factors  for the development of emotional problems as the result of a severe stressor 
(see e.g. Evers et al. 2001; Alloy et al. 1999; Terry & Hynes, 1998; Costa et al. 1996; 
Aldwin 1994; Carver et al. 1993; Cohen and Wills, 1985).  
In previous studies (Verhaak et al. 2001; Verhaak et al. 2005), we have investigated 
short-term emotional response to the first IVF or ICSI treatment cycle (assessments 
took place four weeks after the pregnancy test following the first cycle). In addition, 
we have investigated a comprehensive model that incorporates several important 
risk and protective factors in order to predict the short-term emotional response to 
the first unsuccessful treatment cycle. These studies revealed an increase in anxiety 
and depression after the first unsuccessful cycle. In addition, they supported the 
importance of neuroticism, cognitions of helplessness when faced with fertility 
problems and dissatisfaction with the marital relationship as risk factors for the 
development of higher levels of anxiety and depression. In addition, acceptance of 
fertility problems and perceived social support were indicated as protective factors 
for the development of higher levels of both anxiety and depression.  
In the present paper, we examined long-term emotional response of women to 
consecutive treatment cycles and tested the validity of the comprehensive model for 
investigating factors that contributed to the course of the emotional response to 
repeatedly unsuccessful IVF or ICSI treatment cycles six months after the final 
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cycle. We were interested in the set of factors that account for the most explained 
variance in long-term changes in anxiety and depression. In addition, we explored 
the long-term emotional response to consecutive treatment cycles in men.  
 
Materials and methods 
Participants 
Participants were recruited at a university hospital in a medium-sized city in the 
Netherlands. Inclusion criteria: Dutch-speaking and about to start their first cycle 
of a new IVF or ICSI treatment.  
Three hundred and seventy-five women and 340 of their partners agreed to 
participate. Two hundred and eighty-eight women responded to questionnaires after 
the first treatment cycle (77%). After the last cycle, 205 of these 288 women (71%) 
completed all the questionnaires and 147 of these 205 women (72%) also took part 
in the follow-up assessments. Two hundred and twenty-two of 340 men responded 
after the first treatment cycle (65%). After the last treatment cycle, 125 of these 222 
(56%) responded and 71 of these 125 also took part in follow-up assessments 
(57%). Complete data sets for three measurement points were received from 148 
women (40%) and 71 of their partners (21%). Demographic characteristics for these 
women and their partners are presented in Table 1. 
 
The course of the emotional response was investigated for women and men after 
both unsuccessful and successful treatment. Factors that contributed to the course 
of the emotional response were only investigated in women after unsuccessful 
treatment.  
Differences in response between women and men were due to a last recall 
procedure that focussed on women only.   
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Table 1: Participants’ demographic characteristics (women= 148; men= 71) 
Cause of fertility problems 
Women 
Men 
Both 
Idiopathic 
 
23% 
40% 
  8% 
29% 
 
Already having children 
 
20% 
 
Duration of fertility problems <3 ys 
Between 3 and 5 years 
More than 5 years 
 
26% 
54% 
20% 
 
Mean age of women 
 
34.1  
(range: 21-43) 
 
Mean age of men 
 
36.3  
(range: 26-54) 
 
Design 
Data was collected before the start of medication, i.e. five to ten days before the 
start of the first IVF/ICSI treatment cycle, four weeks after the pregnancy test 
subsequent to this and possible next treatment cycles, and six months after the last 
cycle.  
 
For the present study, data was used from pre-treatment assessments (T1), 
assessments made just after the final cycle (T2) and follow-up assessments (T3). To 
obtain information about how women coped with the unsuccessful treatment cycle 
4 weeks after the pregnancy test following the first cycle, the women were asked to 
complete a coping questionnaire focusing on that treatment cycle.  
A cycle was retrospectively defined as a ‘final’ cycle when couples did not start 
further treatment within one year subsequent to the previous cycle. Exclusive 
criteria for the last treatment cycle are unobtainable, as women may again consider 
participation in treatment options even years after ceasing treatment (Van Balen 
Emotional adjustment before, during and after consecutive fertility treatment cycles 
__________________________________________________________________________________________ 
 
 
127 
and Trimbos-Kemper,1995; Leiblum et al. 1987). Psychological and clinical 
parameters were assessed at T1, before the start of the first treatment cycle.  
Anxiety and depression assessments were repeated at T2 and T3.  
 
Procedure 
Women and their partners were asked to participate in the study when at the 
hospital for an intake interview with their physician prior to their first IVF or ICSI 
treatment cycle. A long protocol (three weeks) was used. After obtaining written 
informed consent, questionnaires were sent to their homes. Women and their 
spouses were asked to complete the questionnaires separately before the start of 
medication and return them to the hospital in a prepaid envelop. In addition, 
participants received a questionnaire four to six weeks after the pregnancy test for 
each cycle.  A final questionnaire followed six months after the last treatment cycle. 
If a new cycle was started within six months after this time (twelve months after the 
last cycle), this questionnaire was not taken into account. The study was approved 
by the hospital ethical research committee. 
 
Measures 
Demographic (age, educational level, number of children) and gynaecological 
(duration of fertility problems) background characteristics were assessed with a 
self-report questionnaire.  
State anxiety and depression were assessed with two standardised questionnaires, 
validated for the Dutch population. State anxiety was measured with the ‘State and 
Trait Anxiety Inventory’ (STAI; Spielberger et al. 1983; Dutch translation: Van der 
Ploeg et al. 2000; 20 items, possible range 20-80). Cronbach's alpha was .90 for 
state anxiety. The score of one standard deviation above the mean for the norm 
group was used as the cut-off for clinically relevant forms of anxiety. This was 48.  
Depression was measured with the ‘Beck Depression Index – PC’ (BDI: Beck et al. 
1997; 7 items, possible range 0-28). Cronbach's alpha was .84. This is a short 
version of the BDI, consisting of items referring only to cognitive aspects of 
depression.  
This makes it possible to assess depression in a medical population without 
confounding between medical problem characteristics and vital aspects of 
depression (Verhaak et al. 2001). The cut-off score for subclinical relevant forms of 
depression was 4 (Beck et al. 1997). 
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Two personality factors were measured, neuroticism and optimism. Neuroticism 
was measured with one subscale of the Dutch version of the ‘Eysenck Personality 
Questionnaire’ (Sanderman et al. 1995; 6 items). The possible range of the scale 
was 0 to 12. Cronbach’s alpha in the present study was .81. Optimism was 
assessed with the optimism scale of the ‘Life Orientation Test’ (LOT: 12 items, 
possible range 0-32), developed by Scheier and Carver (1985) and translated into a 
Dutch version by Vinck et al. (1998). Cronbach’s alpha in the present sample was 
.81.  
 
Infertility-related cognitions of helplessness and acceptance were measured with the 
‘Illness Cognitions Questionnaire’ (Evers et al. 2001), which was adjusted to the 
situation of women facing fertility problems. The possible range of both the 
helplessness and acceptance scales, each consisting of six items, was 6 – 24. An 
example of a helplessness item is: ‘I felt overwhelmed by my fertility problems’.  An 
example of the acceptance scale is: ‘I can handle the problems related to my 
infertility.’ In the present study, Cronbach's alpha was .86 for the helplessness 
scale and .89 for the acceptance scale. 
 
Coping was assessed with the ‘Cope’ (Carver et al. 1989; 39 items). The Cope factors 
were clustered in four groups, resembling factors used by Terry and Hynes (1998) 
in their study on coping with infertility: Problem Management (Cope factors ‘active 
coping’ and ‘planning’; Cronbach’s alpha = .76), problem appraisal (‘behavioural 
disengagement’ and ‘positive reinterpretation’; Cronbach’s alpha = .58), emotional 
approach (‘seeking instrumental support,’ ‘seeking emotional support,’ and ‘venting 
emotions’; Cronbach’s alpha=.86), and cognitive avoidance or escapism (Cope factor 
‘denial’; Cronbach’s alpha = .75). The reliability of the problem appraisal scale was  
too limited and we did not use it in our analyses. 
 
The assessed indicators of social support were satisfaction with the marital and 
sexual relationship as well as general aspects of social support. Marital and sexual 
satisfaction was measured with the general marital satisfaction scale (10 items, 
possible range 0-80) and the sexual satisfaction scale (5 items, possible range 0-40) 
from the ‘Maudsley Marital Questionnaire’ (MMQ: Arrindell et al. 1983). Higher 
scores are an indication of greater dissatisfaction. Cronbach's alpha in the present 
study was .85 for general marital satisfaction and .70 for sexual satisfaction. 
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General aspects of social support were measured with a Dutch self-report 
questionnaire ‘Inventory for Social Support’ (Van Dam-Baggen and Kraaimaat, 
1992), which measures the size of the social network (in terms of the number of 
friends and acquaintances) and perceived social support (20 items, possible range 
5-20). In the present study, Cronbach's alpha was .87 for perceived social support. 
Demographic aspects, anxiety, depression, and marital satisfaction were assessed 
in both women and men, the other variables were assessed in women only.  
 
Statistical analyses 
MANOVAs with repeated measures and post hoc ONEWAY analyses of variance 
were performed to examine differences in the course of anxiety and depression 
between pregnant and non-pregnant participants. Analyses were carried out 
separately for women and men, because of the discrepancy in participation between 
men and women. MANOVAs for repeated measures were performed separately after 
successful and unsuccessful treatment to analyse possible differences in the course 
of anxiety and depression with respect to the number of treatment cycles and 
having children.  
McNemar’s nonparametric test for repeated samples was used to investigate 
differences in the proportion of subclinical forms of anxiety and depression between 
different measurement points.  
Pearson’s correlation coefficients (in the event of nominal variables, Kendall’s rank 
correlation coefficient was used) were calculated between the vulnerability factors 
and anxiety and depression change scores to explore the relationship between 
background characteristics and vulnerability factors assessed prior to treatment 
and changes in emotional status between pre-treatment (T1) and follow-up (T3) 
assessments. Residual gain scores were used as change scores (Kerlinger, 1975). 
Residual gain scores are chance scores in which the influences of pre-test scores 
are removed. They were calculated by regressing T3 scores onto T1 scores, creating 
a new variable: Time 3 with the effect of Time 1 removed. The regression analyses 
were sequentially performed for anxiety and depression at T3, as dependent 
variables. Levels of anxiety and depression at T1 were entered as first predictors. 
Personality characteristics are relatively stable and have been shown to determine 
characteristics like cognitions, coping and social support (Clark et al. 1994). For 
that reason, we entered them in the second step. In the third step,  the additional 
predictors that significantly correlated with change scores in anxiety or depression 
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were entered This procedure provided an opportunity to examine the additional 
predictive value of cognitions, coping and social support, in addition to pre-
treatment anxiety and depression and to relatively stable personality 
characteristics. 
 
Results 
T-tests did not reveal any pre-treatment differences in anxiety (t(1,147)= -.21; 
p=.83), depression (t(1,147)= .48; p=.63), marital dissatisfaction (t(1,147)= .50; 
p=.62) or sexual dissatisfaction (t(1,147)= .74; p=.46) between women whose 
spouses did or did not participate in the study at all or dropped out during the 
study.  
However, six months after the last treatment cycle, women whose spouses did not 
participate showed higher levels of depression (t(1,147)= 3.17; p=.002) and a trend 
of higher levels of anxiety (t(1,147)= 1.79; p=.08) than women whose spouses did 
participate in the study. 
  
In addition, t-tests did not reveal any significant difference in pre-treatment anxiety 
(t(1,375)= -.20; p=.84) and depression (t(1,375)= -.29; p=.78) between women who 
completed all questionnaires and women who did not. This was the same for 
anxiety (t(1,205)= -.68; p=.50) and depression (t(1,205)= -.13; p=.91) just after the 
last treatment cycle.  
 
Eighty-three women (56 %; with 54 partners included in the study) got pregnant 
after one or more treatment cycles, 66% of these 83 after one cycle, 25% after two 
cycles, 6% after three cycles and 3% after four or more cycles. The other 65 (44%; 
with 17 partners included in the study) did not get pregnant; 27% of these 65 
completed one treatment cycle, 26 % two cycles, 35% three cycles and 12% four or 
more cycles. The average time between T1 and T2 was three months (range 2 – 4). 
The average time between T1 and T3 was 16 months (range 8 – 36).     
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Course of anxiety and depression 
The descriptive results of anxiety and depression levels at the various assessment 
points are presented in Table 2. The correlation between anxiety and depression 
was .62 at T1, .73 at T2 and .76 at T3.  
MANOVAs for repeated measures were performed in order to investigate the 
differences in the course of anxiety and depression between T1, T2 and T3 for 
women and men after successful and after unsuccessful treatment.  
 
Table II: Mean scores for state anxiety and depression in women after successful (n 
= 83) and unsuccessful (n=65) treatment and in men after successful (n=54) and 
after unsuccessful (n=17) treatment at T1 (pre-treatment), T2 (after the final 
treatment cycle) and T3 (six months after the final treatment cycle). 
 
 pregnant 
women 
non-pregnant 
women 
men with 
pregnant 
women 
men with  
non-pregnant 
women 
State anxiety T1 36.7 (10.1) 37.3 (11.7) 32.8 (6.8) 33.5 (11.7) 
State anxiety T2 33.5 (8.7) 40.2 (11.8) 32.3 (6.9) 34.9 (10.2) 
State anxiety T3 34.2 (8.5) 39.0 (13.6) 32.3 (8.6) 32.4 (8.0) 
Depression T1 1.5 (1.8) 1.5 (2.3) 0.7 (0.9) 1.0 (1.3) 
Depression T2 0.8 (1.3) 2.3 (2.7) 0.6 (0.9) 1.5 (2.2) 
Depression T3 0.5 (0.9) 2.3 (2.9) 0.4 (1.1) 0.8 (1.0) 
 
The results of the MANOVAs for women did not reveal any significant effect for time 
for either anxiety or depression. However, a significant interaction effect for time x 
treatment outcome was indicated for anxiety (F(2,146)= 6.5; p=.00) and for 
depression (F(2,146)= 12.9; p=.00). In addition, there were significant effects for 
treatment outcome for both anxiety (F(2,146)= 7.5; p=.01) and depression (F(2,146)= 
16.1; p=.00). Post hoc t-tests for non-pregnant women revealed a significant 
increase in both anxiety (t(1,64)= -2.5; p =.02) and depression (t(1,64)= -2.9; p=.01) 
between T1 and T2, while pregnant women showed a decrease in anxiety (t(1,82)= 
3.2; p=.00) and depression (t(1,82)= 3.4; p=.00) in the same period. Post hoc t-tests 
did not reveal any change in anxiety (t(1,64)= -.74; p=.46) or depression (t(1,64)= 
.18; p=.86) between T2 and T3 in both pregnant and non-pregnant women.  
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The results of the MANOVAs for men did not reveal any significant time, interaction 
or treatment outcome effects for anxiety or any interaction and outcome effects for 
depression. They did reveal, however, a significant time effect for depression 
(F(2,69)= 5.1; p=.01). Post hoc t-tests for men after successful treatment revealed a 
significant decrease in depression (t(1,53)= 2.7; p=.01) between T2 and T3. The post 
hoc t-tests did not reveal any other significant results. 
 
Differences in the course of anxiety and depression with respect to number of 
treatment cycles and already having children 
Additional MANOVAs were performed for women who did not get pregnant in order 
to investigate possible differences in the course of anxiety and depression with 
respect to the number of unsuccessful treatment cycles undergone.  
 
These MANOVAs did not show any differences in the course of anxiety and 
depression between women who ceased treatment after two or less cycles versus 
three or more (interaction effect time x number of cycles: F(2,63)= 1.06; p=.35 for 
anxiety and F(2,63)= .24; p=.78 for depression; time effect: F(2,63)= .02; p=.83 for 
anxiety and F(2,63)= 1.19; p=.28 for depression). In addition, MANOVAs performed 
in order to investigate differences in the course of anxiety and depression between 
women with and without children did not reveal any significant difference in the 
course of anxiety (time x children F(2,63)= .18; p=.83; children F(2,63)= .00; p=.96) 
or depression (time x children F(2,63)=1.13; p=.33; children F(2,63)= .00; p=.99). 
MANOVA’s for men were not performed because of insufficient sample size (N=17). 
 
Subclinical forms of anxiety and depression 
At T1, before the start of the first treatment cycle, 13% of the women in the 
unsuccessful group scored above the cut-off scores for subclinically relevant forms 
of anxiety. This was 23% at T2 and 20% at T3. Six percent showed subclinical levels 
of anxiety at T2 as well as at T3. With respect to subclinical forms of depression at 
T1, 12% of the women who did not get pregnant scored above the cut-off. This was 
20% at T2 and 25% at T3. This was a significant increase from T1 to T3 (McNemar: 
p=.04). Again, 6% showed subclinical levels of depression anxiety at T2 as well as at 
T3. At all measurement points, the percentage of men of both pregnant and non-
pregnant wives who scored above the cut-off for clinically relevant forms of anxiety 
and depression varied from 0 to 2 percent. 
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Factors that contributed to the course of anxiety and depression after unsuccessful 
treatment. In Table 3, correlations of change scores for anxiety and depression 
between T1 and T3 with background variables and predictors are presented.  
 
Table III: Pearson correlation coefficients between predictors and change scores for 
anxiety and depression between T1 and T3 
 
 Total course (T1 – T3) 
 Anxiety Depression 
Demographic 
   -        Age 
 
.08 
 
.15 
Clinical 
      -      Duration of infertility 
 
-.20 
 
-.17 
Personality characteristics 
Neuroticism 
Optimism 
 
.31* 
-.22 
 
.47** 
-.34** 
Infertility-related cognitions 
Helplessness 
Acceptance 
 
.10 
-.17 
 
.32* 
-.31** 
Coping  
Problem management 
Emotion Approach 
-    Cognitive avoidance  
 
.06 
.22 
.08 
 
-.01 
.11 
-.15 
Social support 
General marital dissatisfaction 
Sexual dissatisfaction 
-     Perceived social support 
 
.30* 
.15 
-.37** 
 
.28* 
.23 
-.34** 
** p < .01; *p < .05 
 
In predicting the change in anxiety from T1 to T3, factors which correlated 
significantly with the change score of anxiety were selected for the regression model: 
neuroticism, general marital dissatisfaction and perceived social support. 
Correlations between the different predictors are presented in Table 4. 
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Table IV: Intercorrelations for predictor variables  
 1 2 3 4 5 6 7 
1. Neuroticism -- -.35** .31* -.34** .46** .21 -.41** 
2. Optimism  -- -.14 .11 -.39** -.08 .06 
3. Helplessness   -- -.60** .13 .12 -.19 
4. Acceptance    -- -.09 -.27* .30* 
5. Marital 
dissatisfaction 
    -- .30* -.38** 
6. Sexual dissatisfaction      -- -.20 
7. Perceived social 
support 
      -- 
** p<.01; * p< .05 
 
The results revealed that T1 levels of anxiety (delta R2= .27; p<.001), neuroticism 
(delta R2 = .08; p<.01) and perceived social support, together with general marital 
dissatisfaction (delta R2= .07; p<.05) added significant additional variance in anxiety 
levels at T3. The model with these factors fully explained 42% of the variance in 
anxiety at T3 (R2= .42; p<.05). 
 
In predicting depressed mood at T3, the six factors that correlated significantly with 
the change score were taken into account and entered in the regression analysis: 
baseline levels of depression in the first step, personality characteristics 
neuroticism and optimism in the second step, cognitions of infertility (helplessness 
and acceptance) in the third step and social support (general marital dissatisfaction 
and perceived social support) in the last step. The results revealed that baseline 
levels of depression (delta R2= .09; p<.05), and personality characteristics (delta R2= 
.22; p<.001) added significant additional variance in depression levels at T3. The 
model that explained the most variance (R2= .36; p<.000) consisted of baseline 
levels of depression, neuroticism, optimism, helplessness, acceptance, perceived 
social support and general marital dissatisfaction. However, cognitive and  social 
support factors did not significantly explain additional variance. 
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Discussion 
One apparent result of the present study is the lack of emotional recovery in the six 
months after the end of treatment. Following theories on cognitive adaptation 
(Folkman, 1984; Taylor, 1983), one might expect a decrease in distress after 
abandoning treatment. This lack of recovery in the present study might be 
explained by the length of recovery period that was taken into account. Six months 
could be too short to identify beneficial effects of changing the meaning of infertility 
(Bananno & Kaltman, 2001). Another explanation might be found in the 
continuation of uncertainty about the definitive character of the childlessness 
which is in line with studies indicating that couples still keep new treatment 
possibilities in the back of their mind for a considerable time after the end of 
treatment (Van Balen et al. 1993; Leiblum et al. 1987).This seems to interfere with 
the cognitive adaptation, necessary to adjust to definitive childlessness (Folkman, 
1984; Taylor, 1983).  
The next apparent finding is the importance of wide range of factors that 
determined the emotional adjustment to infertility. Personality characteristics, 
cognitive factors, and social support were found to be important in this process. By 
investigating the predictive power of these factors in a stress vulnerability model, 
their relative importance could be noticed. The importance of neuroticism is in line 
with theories and empirical evidence regarding the interrelationship between 
anxiety and depression to neuroticism. Both emotions share the central aspect of 
negative affectivity or neuroticism (Clark et al. 1994).  
The present study also supported the importance of social support as a buffer in 
the relationship between the stressor of unsuccessful treatment and emotional 
response. With respect to fertility problems, the spouse seems to be the most 
important source of social support (Laffont et al. 1994). 
After controlling for personality characteristics and social support, cognitions of 
acceptance helplessness determined the course of depression. The importance of 
cognitive adaptation in terms of changing meaning in the adjustment to 
unsuccessful IVF is expressed in higher levels of acceptance as assessed in the 
present study and related to a more favourable adjustment to unsuccessful 
treatment. A lack of adaptation in terms of the inability to regain control, as 
assessed in higher levels of helplessness, is related to poorer outcome. Women have 
to make a shift from active, treatment focused ways to deal with the fertility 
problems to cognitive ways of adjustment in terms of changing the meaning of 
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childlessness. This is in accordance to theories stressing the importance of 
changing meaning in long term adjustment to severe health problems (Folkman, 
2001; Folkman, 1984; Taylor, 1983; Rothbaum et al. 1982).  The importance of 
personality characteristics, meaning of infertility and social support as predictors of 
the emotional adjustment to unsuccessful IVF is in line with the results of a 
previous study into the adjustment to one unsuccessful treatment cycle on the 
present sample (Verhaak et al. 2005). 
 
In the present study, coping factors did not determine the adjustment to 
unsuccessful treatment. The effectiveness of coping partly depends on the 
characteristics of the stressor (Suls and Fletcher, 1985; Penley et al. 2002). The 
infertility stressor is highly uncontrollable (Miller-Campbell et al. 1991). 
Accordingly, ways to actively change the stressor are limited. That is why active and 
problem-focused coping are assumed to be ineffective. The results of the present 
study partly support this: there was no relationship found between problem-
focused, active coping and changes in anxiety or depression. Some studies found 
support for effective coping being related to what they called emotional approach 
coping in the event of uncontrollable stressors: minimizing the threatening 
evaluation of the stressor and accepting its occurrence (Austenfeld and Stanton, 
2004; Berghuis and Stanton, 2002; Terry and Hynes, 1999). The negative 
relationship between cognitions of acceptance of fertility problems and increase in 
depression between T1 and T3 in the present study is in line with these results. 
Findings from the present study did not support the expected positive relationship 
between avoidant coping and anxiety or depression. This might partly be due to the 
complexity of the stressor, the time lag between coping assessment and emotional 
response and the general way coping was assessed. Effective coping depends on the 
characteristics of the stressor. The stressor in the present study is complex: it is the 
stressor of the treatment itself, of uncertainty and of a loss of hope for pregnancy 
and children.  
All these aspects might require different coping strategies: Avoidant coping seems to 
be efficacious during times of uncertainty (Miller and Mangan, 1983) Re-evaluation 
of the stressor seems to be important in the event of loss (Davis and Nolen 
Hoeksema, 2001). It is possible that a stronger coping effect might have been found 
if coping efforts related to these aspects of the stressor were separately assessed  In 
addition, the effectiveness of avoidant coping seems to depend on the time lag 
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between the stressor and emotional response: avoidant coping seems to be more 
effective in the short term (Suls and Fletcher, 1985). It is possible that avoidant 
coping could determine short-term emotional response to unsuccessful treatment .  
The long period over which assessments took place is a strength of the present 
study. Nevertheless, prolongation of this period to two years after the final 
treatment cycle would provide more information about the course of emotional 
adjustment to successful and unsuccessful treatment. This would be particularly 
interesting for the group of women who only recently (at follow-up) showed clinically 
relevant forms of anxiety or depression. Previous studies show equivocal results 
about the course of adjustment to a severe stressor. Some previous studies have 
indicated that high levels of depression shortly after incidence of the stressor are 
important risk factors for the development of a major depressive disorder in the 
near future (Howarth et al. 1994). Other studies, however, have indicated that the 
adjustment process normally takes two years, after which most people seem able to 
adequately adjust (Bonanno and Kaltman, 2001; Janssen et al. 1997). 
A difficult aspect of the study was definition of the final treatment cycle. It hardly 
seems possible to investigate emotional response to definite infertility. There are 
couples who take a long break between cycles. Other couples hesitate for a long 
time before making another attempt. Previous studies have pointed out that half of 
the women who have stopped fertility treatment would restart if there were new 
treatment possibilities (Van Balen and Trimbos-Kemper 1995; Leiblum et al. 1987). 
It seems as if the hope of ever conceiving a child only diminishes with age. And even 
this criterion could perhaps change in the near future. 
The high percentage of women that display subclinical forms of anxiety and 
depression even six months after the final treatment cycle is clinically important. 
The present study provided information for identifying these women before the start 
of the treatment, which will make it possible to offer these risk groups additional 
counselling in time. The counselling should be focused on the meaning or the 
cognitions of fertility problems and on improving social support. Future studies will 
have show whether these counselling efforts prevent the development of severe 
emotional problems.  
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Abstract 
 
Background: The aim of the present study was to gain more insight into long-term 
psychological adjustment to IVF in women. 
Methods: In a prospective cohort study, 298 women entering their first IVF 
treatment cycle (including ICSI) completed standardized psychological 
questionnaires before the start of the treatment, just after the last treatment cycle, 
and six months and three to five years after the last treatment cycle. The main 
outcome measures were state anxiety, depression and mode of adaptation to 
unsuccessful IVF. 
Results: anxiety and depression were found at follow-up to return to baseline levels 
following treatment not resulting in a live birth after an initial increase during 
treatment. On the other hand, treatment resulting in a live birth was found to lead 
to a more positive long-term emotional status. Women who focused on new life 
goals as a mode of adaptation three to five years after IVF without a live birth 
showed lower levels of anxiety and depression compared to those who persisted in 
their attempts to get pregnant. 
Conclusions: treatment that resulted in a live birth led to more positive emotional 
adjustment. In addition, a majority  of the women who did not give birth to a child 
after treatment adjusted well psychologically. Positive adjustment was related to 
developing new life goals rather than persisting in attempts to get pregnant. Helping 
women to change life goals after abandoning treatment might have beneficial effects 
on the adaptation process.  
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Introduction 
IVF treatment is physically and emotionally stressful. The unfulfilled desire to have 
a child, and the consequent threat of permanent infertility were related to increased 
levels of anxiety and depression during IVF treatment (Verhaak et al. 2001). 
Numerous studies have been published on psychological aspects of IVF treatment. 
Until now, however, the long-term psychological consequences of IVFhave rarely 
been investigated. An earlier study found that six months after the last 
unsuccessful treatment more than 20% of the women showed clinical forms of 
anxiety and/or depression (Verhaak et al. 2005). It is known that a high level of 
depression shortly after the incidence of a stressor is a major risk factor for the 
development of a depressive disorder in the near future (Howarth et al. 1994).  
On the other hand, cross-sectional studies have indicated that, in general, couples 
seem to adjust to their infertility (Hammarberg et al. 2001, Leiblum et al. 1998, 
Weaver et al. 1997; Freeman et al. 1987). A retrospective study indicated that the 
longer the time passed since the last IVF treatment cycle, the better the emotional 
adjustment (Baram et al. 1988). This is in line with the finding that the adjustment 
process normally takes about two years, after which most people seem able to 
adjust well (Bonanno & Kaltman 2001; Janssen et al. 1997).  
Positive adjustment to infertility was shown to be related to abandoning medical 
treatment and focusing on new life goals, whereas pursuing pregnancy was related 
to more negative adjustment (Van Balen & Trimbos-Kemper 1994). This is in 
agreement with the longitudinal, qualitative study by Daniluk (2001) into emotional 
adjustment after unsuccessful fertility treatment, which indicated that ‘turning 
towards the future’ is an important aspect.   
Since longitudinal studies on the course of the emotional response before, during 
and several years after unsuccessful treatment are non-existent, the question 
remains what happens to those women who did not succeed in getting pregnant. A 
longitudinal follow-up study could provide us with information about the number of 
patients developing clinical forms of anxiety and/or depression after treatment. 
Furthermore, it could provide insights into subsequent modes of adaptation. The 
aim of the present study was therefore to gain a greater insight into the longitudinal 
adjustment of women in IVF. This could provide us with more information about 
the desirability of tailored support after IVF is abandoned. 
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Materials and methods 
Sample 
The data used were from women who came for the first cycle of a new IVF treatment 
(including 38% who underwent ICSI) at the Radboud University Nijmegen Medical 
Center in the Netherlands between 1998 and 2000. This group participated in a 
previous prospective follow-up study on the psychological aspects of IVF treatment. 
Of the 450 women contacted, 380 (84%) agreed to participate at the start of the 
previous study (T1). Participants were asked to complete questionnaires on 
psychological factors before the start of treatment (T1), after the last treatment cycle 
(T2), and six months after the last cycle (T3). Last treatment cycle was defined as 
not starting a  new cycle, one year after the end of the previous cycle.  Three to five 
years after T1, the 380 women who completed the T1 assessment were again invited 
to participate in a long-term follow-up assessment (T4).  
All participants were guaranteed confidentiality and a separation of the 
questionnaire information on psychological, marital and sexual factors and their 
clinical management. Written informed consent was obtained from all participants. 
 
Psychological measures 
State anxiety was measured by means of the Dutch version of the State and Trait 
Anxiety Inventory (Spielberger et al. 1970), a scale that shows satisfactory reliability 
and validity. The inventory has 20 items that assess state anxiety; the score for 
each item ranges from 1 to 4, with higher scores indicating greater state anxiety. 
Total scores therefore range from 20 to 80. The cut-off for clinical state anxiety was 
48, which is one standard deviation above the mean for the age-matched norm 
group of Dutch women (Van der Ploeg et al. 2000).  
Depression was measured by means of the short Dutch version of the Beck 
Depression Inventory (BDI) (Beck et al. 1997). This scale is one of the most widely 
used, reliable and valid instruments for assessing intensity of depression and for 
detecting depression in the general population. The scores for each item range from 
0 (low) to 3 (high). The cut-off for clinical depression was a total score of 4. 
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Furthermore, four modes of adaptation were distinguished (according to Van Balen 
& Trimbos-Kemper 1994):  
1 medical mode: still pursuing medical options in order to have a biological 
child of their own; 
2 passive mode: not actively pursuing the desire, but still having the desire for 
a child; 
3 alternative mode: pursuing other ways of having a child (e.g. adoption); 
4 new goals: abandoning the desire to have a child and choosing other life 
goals. 
 
Statistical analysis 
Comparisons were made between women who gave birth to a child after the start of 
their IVF treatment (spontaneous pregnancies after the start of treatment were also 
taken into account) and women who did not.  All statistical analyses were 
performed using the SPSS program (SPSS version 12.0). The course of anxiety and 
depression over time and differences in that course between women who gave birth 
to a child after their treatment and those who did not was examined using 
multivariate analysis of variance (MANOVA). Post-hoc, one-way analyses of variance 
were performed to examine the course of anxiety and depression in women who 
gave birth to a child after their treatment and those who did not. T-tests were used 
to compare women who gave birth and those who did not after treatment and to 
compare anxiety and depression at different times. One-way ANOVAs were used to 
compare anxiety and depression in women with different modes of adaptation.  
This study was approved by the institution’s ethical committee.  
 
Results 
Of the 380 women who participated in the previous study, 298 (78% of the 
participants) completed an additional set of questionnaires three to five years after 
treatment (T4). Sixty-four women (21%) already had a child before the start of the 
treatment. One hundred and ninety-three women (65%) gave birth to a child after 
IVF, 105 women (35%) did not. A non-participation study (n=82 of 380) showed a 
trend towards more non-responders (women who did not respond to T4) among 
women who did not succeed in giving birth to a child after treatment (chi=3.37; 
p=.07).  
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The mean age of the women was 33.4 years (SD=4.1). Thirty-one per cent completed 
ten years of education or less, 39% completed 11 to 14 years of education and 30% 
completed 15 years of education or more. All the women were part of a heterosexual 
couple at the start of the treatment, 96% was born in the Netherlands and 98% was 
Dutch. The causes of the fertility problems were as follows: female factor in 17% of 
the women, 39% male factor, 8% both male and female factors and 28% unknown.  
 
After abandoning their treatment in the hospital where the study was carried out, 
seven per cent (n=22) of the respondents went for treatment elsewhere; eight of 
them (36%) subsequently gave birth to a child. The options indicated were: intra-
uterine insemination with donor semen (n=4), intra-uterine insemination with own 
semen (n=1), IVF at another clinic (n=10), homeopathic medicine (n=1), other 
medication (n=1), and alternative medicine (n=5), which included acupuncture, 
magnetism and ayurvedic therapy.  
 
The course of anxiety and depression over time was studied using MANOVAs, 
comparing women who did and did not give birth after treatment. When only the 
pre-treatment data (T1) and data from three to five years after treatment (T4) were 
considered, a significant interaction effect was found for time and birth, both for 
anxiety (F=3.9; p=.05) and depression (F=12.2; p<.01).  
 
Table I: Anxiety and depression at pre-treatment (T1) and follow-up (T4) in women 
who gave birth after IVF (n=193) and those who did not (n=105) 
 Pre-treatment 
(SD) 
Follow-up (SD) Univariate test 
Anxiety1 
Gave birth after IVF 
Did not give birth 
after IVF 
 
36.1 (8.9) 
 
37.7 (12.2) 
 
34.2 (7.6) 
 
37.7 (10.6) 
 
t=2.6; p=.01 
 
not significant 
Depression2 
Gave birth after IVF 
Did not give birth 
after IVF 
 
(1.5) 
 
1.3 (1.9) 
 
0.5 (1.3) 
 
1.5 (2.2) 
 
t=5.0; p<.01 
 
not significant 
1significant interaction effect time x birth: F=3.9; p=.05 
2significant interaction effect time x birth F=12.2; p<.01 
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In further analyzing the effect, a significant decrease in anxiety (t=2.6; p=.01) and 
depression (t=5.0; p<.01) was found in women who gave birth to a child. The scores 
for anxiety and depression for women who did not give birth to a child did not differ 
significantly between pre-treatment and three to five years after treatment. 
 
A complete dataset was obtained for 107 women (T1,T2,T3,T4); 68 women gave 
birth to a child after treatment and 39 women did not. The smaller sample size was 
due to incomplete data at T2 and T3. Comparisons of anxiety and depression at T1 
and T4 did not reveal significant differences between responders and non 
responders at T2 and T3. The same was true for pregnancy rates.   
 
Table II: Anxiety and depression at different times during and after IVF (N=107; 68 
live birth after IVF, 39 no live birth after IVF) 
 
  
T1:  
Pre-
treatment 
(SD) 
 
T2:  
Just after 
treatment 
(SD) 
 
T3:  
6 months 
after 
treatment 
(SD) 
 
T4:  
3-5 years 
after 
treatment 
(SD) 
Anxiety1 
-  Gave birth after IVF 
- Did not give birth after IVF 
 
36.2 (9.6) 
36.9 (13.1) 
 
32.8 (8.2)3 
39.8 (14.5) 
 
34.0 (8.4) 
40.3 (15.5) 
 
33.9 (7.5) 
37.1 (11.1) 
Depression2 
- Gave birth after IVF 
- Did not give birth after IVF 
 
1.2 (1.5) 
1.3 (3.9) 
 
0.7 (1.0) 4 
3.9 (3.4)6 
 
0.5 (0.9) 
2.6 (2.9) 
 
0.5 (1.5) 5 
1.7 (2.2) 
1 Significant interaction effect time x birth: F=3.5; p=.02 
2 Significant time effect: F=3.2; p=.02; significant interaction effect time x birth: 4.5; 
p<.01 
3 Significant decrease T1-T2: t=3.1; p=.03 
4 Significant decrease T1-T2: t=2.6; p=.01 
5 Significant decrease T1-T4: t=3.0; p<.01 
6 Significant increase T1-T2: t=2.1; p=.05 
 
Chapter 9 
__________________________________________________________________________________________ 
 
 
152 
The data are shown in Table 2. In analyzing the data, a significant effect over time 
was found for depression (F=3.2; p=.02). No significant main effect for anxiety was 
found. Furthermore, a significant interaction effect on time x birth was revealed for 
both anxiety (F=3.5; p=.02) and depression (F=4.5; p<.01). More specifically, in this 
particular subgroup a significant decrease in anxiety was found in women who gave 
birth when comparing T1 and T2 (t=3.1; p=.03), and significantly lower levels of 
depression were found when comparing T1 and T2 (t=2.6; p=.01) and T1 and T4 
(t=3.0; p=<.01). In analyzing the women who did not give birth after treatment, 
higher levels of depression were found at T2 compared to T1 (t=2.1; p= .05).  
When only the percentages of the group with clinically relevant forms of depression 
were considered, at pre-treatment (T1) 12% scored above the cut-off level; just after 
the last treatment cycle (T2) 20%; six months later (T3) 25%; and three to five years 
later (T4) 16%. When clinically relevant forms of anxiety were considered, the 
percentages were 13% at T1, 23% at T2, 20% at T3 and 15% at T4.  
 
Ninety of the 105 women (86%) who did not give birth provided information about 
their mode of adaptation. The following modes of adaptation were indicated: 
medical mode 12% (n=11), alternative mode 13% (n=12), passive mode 38% (n=34), 
and new goals 37% (n=33). The mean anxiety and depression scores are shown in 
Table 3.  
 
Table III: Anxiety and depression according to mode of adaptation at follow-up after 
treatment not resulting in live birth (N=90) 
Mode of adaptation N Anxiety Depression 
Still pursuing pregnancy wish    
-  Persisting with treatment 11 44.2 3.8 
-  Still longing for a child 34 42.7 2.1 
New life goals    
-  New goals 33 32.1 1.5 
-  Adoption 12 34.8 0.4 
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Significant differences in anxiety (F=10.1; p<.01) and depression (F=9.1; p<.01) were 
found between the different groups. Significantly higher levels of anxiety and 
depression (anxiety: t=4.53, p<.01; depression: t=4.51, p<.01) were found in the two 
groups still pursuing a desire for pregnancy (medical and passive mode), compared 
to the two groups of women who had abandoned their active pursuit of pregnancy 
(new life goals and alternative mode). These differences were the same when women 
who already had a child before treatment were left out of the analyses (data not 
shown). 
 
At T4,19% (n=20) of the women who did not succeed in getting pregnant already 
had a child before the start of the treatment. A comparison of anxiety and 
depression at follow-up (T4) between these women and the women who did not 
succeed in getting pregnant with their first child revealed more anxiety and 
depression in childless women (F=4.58; p=.03 for anxiety and F=8.04; p<.01 for 
depression). 
 
Discussion 
This study followed up a cohort of women who underwent IVF treatment. 
The most striking result was that anxiety and depression were found at follow-up to 
return to baseline levels after an initial increase during treatment in women who 
did not give birth after treatment. Treatment resulting in a live birth was found to 
result in a more positive long-term emotional status. New life goals and already 
having a child before treatment started were found to be associated with lower 
levels of anxiety and depression. 
A limitation of the study is the high drop-out rate at various stages during the 
treatment, which resulted in a limited complete dataset. Furthermore, a drop-out 
analysis revealed higher levels of drop-out in women who did not give birth to a 
child. Despite these limitations, this was the first time a large cohort was studied 
before, during and after treatment. This enabled us not only to analyze the course 
of anxiety and depression, but also to investigate the women’s attitude to 
childlessness and possible further treatment after abandoning IVF. 
Longitudinal follow-up studies, as indicated, are scarce. Cross-sectional follow-up 
studies of the emotional status of involuntarily childless women and women with 
children indicate no important differences between these groups (Hammerberg et al. 
2001, Leiblum et al. 1998, Weaver et al. 1997). This is in line with the present 
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longitudinal study, which shows no differences in the emotional status of the 
women before treatment started and several years after unsuccessful treatment. 
However, the women who gave birth to a child after treatment showed a more 
positive emotional status compared to the baseline. This indicates a positive effect 
of pregnancy and motherhood on emotional status for women with fertility 
problems. This is supported by studies in definitively childless women, who showed 
comparable emotional status but less life satisfaction than women with children 
(Leiblum et al. 1998; Singh & Williams 1981).     
The availability of psychological counselling services was indicated as being vitally 
important at times of distress. It was indicated that ongoing counselling should be 
part of having IVF treatment and that the clinic should contact couples between 
treatments, since only a small proportion of the women availed themselves of the 
counselling services beyond the initial mandatory counselling session. On the other 
hand, it was already known that the most distressed patients fail to initiate contact 
with counsellors (Boivin et al. 1999). There should therefore be a reassessment of 
each couple’s feelings and degree of psychological distress after each IVF cycle 
(Guerra et al. 1998). Couples should be made aware that unsuccessful IVF 
treatment is associated with increased levels of anxiety and depression after 
treatment (Verhaak et al. 2001; Baram et al. 1988), and that this is a normal 
response and the effect is still present six months after the last IVF cycle (Verhaak 
et al. 2005; Slade et al. 1997).  
Furthermore, successful IVF was also found to be associated with increased levels 
of anxiety in comparison with women who had conceived naturally (Hjelmstedt et 
al. 2003). Levels of stress related to parenthood, on the other hand, were found to 
be equal whether women had conceived with or without IVF (Hjelmstedt et al. 
2004). Although it was found that long-term emotional well-being was not affected 
by the fact of a live birth child, approximately 15% of the women whose treatment 
did not result in a live birth reported clinical levels of anxiety and/or depression. A 
strong relationship was found between emotional distress and mode of adaptation, 
since pursuing a desire for pregnancy was found to be associated with higher levels 
of anxiety and depression.  
The clinical implication of the findings of this study points in the direction of 
additional support at the time people are abandoning treatment. Persisting with 
treatment options seems to negatively effect adaptation to childlessness because of 
an enduring uncertainty that results in a lack of control (Daniluk, 2001). Clinicians 
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could address the issue of abandoning treatment in their final consultations and 
inform patients about the emotional consequences of letting go their attempts to get 
pregnant. Indicating that grief is a natural response might help patients to 
understand their emotions. In addition, the prospect of most women adjusting well 
after several years might encourage women to give up treatment and focus on other 
life goals. However, psychosocial support during the decision process after IVF is 
still a relatively uncharted area. Further research is needed to shed more light on 
the process of leaving treatment and focusing on other life goals.  
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Technical advances and economic prosperity have led to an optimistic society, 
where individual hopes, wishes and choices are more important than ever. In a 
health care setting we are generally being faced with an increasingly well-informed 
clientele, who expect to be successful. Failure is not an option, not in daily life, not 
in medicine. In general doctors go along with, or even stimulate this way of 
thinking. Prognostic models were launched that seem to enable individual 
counselling, for instance regarding their chances of success. Pre-treatment 
indicators of outcome and seemingly better treatment regimes are regularly 
introduced, stressing the feeling that the future can be predicted and shaped as 
pleased. 
 
Postponement of having a first child has led to increased subfertility and a bigger 
demand for assisted reproductive techniques. Once IVF is the treatment of choice, 
couples tend to overestimate their individual chances of success prior to the start of 
treatment. This observation is probably due to a self protective mechanism, maybe 
due to lack of information, but surely as a reflection of optimism. After treatment 
has begun it is not only the physical hardships of treatment have to be dealt with, 
but an unsuccessful outcome is often not realistically anticipated. Consequently, 
the unsuccessful couples are left alone with nothing but shattered dreams which 
may continue into the long term. The present thesis is aimed at studying IVF by 
focussing on a stepwise integration of biomedical and psychological factors to 
describe the IVF treatment. In addition, the consequences and implications for daily 
practice are being discussed.  
 
In the first part of this thesis existing and new prognostic biomedical factors in IVF 
were studied. Given the enormous amount of research being done in this particular 
field, this is a logical starting point to study IVF. First a landmark model was 
validated and it was shown that this model is not applicable nor usable in the daily 
clinical practice (of our hospital). The factors presented did not give additional 
information about the prognosis for the vast majority of the patients, suggesting 
that the model could not explain the variance of the outcome sufficiently. Models 
were once more found to be population specific and the application of a model to 
individuals of another population, remains, to say the least, unsatisfactory. 
The next step was to study other pre treatment factors that were launched the last 
decade claiming additional prognostic capacity with respect to treatment outcome. 
Epilogue 
__________________________________________________________________________________________ 
 
 
161 
None of the biomedical, ultrasound and hormonal factors had predictive capacity 
(and consequently no explained variance) with respect to pregnancy after treatment.  
Finally, a new potential marker, FSH-isoforms, were explored with respect to their 
predictive capacity towards the outcome of IVF. Although very promising from a 
theoretical point of view, it was found that it is unlikely that this factor is predictive 
of the outcome. 
In summary, we were not able to predict outcome in a relevant manner per 
individual. Therefore, we should consider ceasing to pretend we can, and therefore 
not exclude patients from treatment based merely on these tests. Ovarian reserve 
tests, if applied, should be reserved for a ‘high risk’ population, since they are not 
suitable to screen the general population. Criteria that could justify screening 
include; female age older than 35, unexplained infertility (regardless of age), family 
history of early menopause, previous ovarian surgery, chemotherapy, radiation, 
smoking and earlier poor response to exogenous gonadotropin stimulation (Speroff 
and Fritz eds).  
Grossly abnormal test results could give more prognostic information and can help 
to guide the choice of treatment. Patient and doctor focus groups might be used to 
determine a clinical relevant cut off point by using a trade off scenario (more 
extreme cut-off values lead to better prognostication, but consequently to lower 
numbers of patients that can be prognosticated). But in the end, one cannot predict 
who will be among those few with abnormal test results that succeed, since a 
binominal prognostication (0 or 100%) is an utopia.  
Exclusion from further treatment is therefore better based on clinical data, since a 
trial of treatment is the only way to identify the women that have a (small) chance of 
pregnancy. From this point of view, the first cycle might be considered a 
diagnostically one, as a part of the integral infertility evaluation (as proposed by the 
research group of te Velde et al. Utrecht, the Netherlands). However, the 
reimbursement system in the Netherlands was revised recently. This now in fact 
punishes couples that undergo only one cycle of IVF, since only the second and 
third cycle are reimbursed. 
 
In the second part of the thesis psychological factors and biomedical factors were 
integrated in a holistic model to look for additional explained variance with respect 
to the outcome. Pre-existing psychological factors were found to be independently 
related to treatment outcome in IVF. This underlines the fact that psychological 
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factors could well be a co-factor in the chance of pregnancy after treatment. A 
significant effect was found, triggering to do further research regarding the 
mechanisms involved. However, the explained variance with respect to pregnancy 
chance was limited.  
Not only pregnancy, but also dropout was being explored as outcome measure. 
Dropout rates were found to be related to psychological factors. But also voluntary 
withdrawal was found to be an important factor in dropout, indicating individual 
freedom of choice during fertility treatment. Avoiding treatment, or discontinuing 
treatment and maintaining the option of returning to treatment was hypothesized 
as a way of couples to protect their fragile dreams and avoid further painful failures 
(Penzias 2004).  
Next, the relation between psychological factors and pregnancy after IVF was 
explored within a subgroup. In women with successful treatment lower 
concentrations of adrenaline were found at ovum pick-up, also lower concentrations 
of adrenaline and nor-adrenalin were found at embryo transfer, in comparison to 
unsuccessful women. The significant association of lower adrenaline concentration 
with pregnancy and with depression suggested that this adrenal hormone could be 
one of the links in the complex relationship between psychosocial stress and 
outcome after IVF. In line with the findings of the questionnaire-based study the 
clinical relevancy was less clear as a large overlap was found between successful 
and unsuccessful treatments. Consequently, it was not possible to define a specific 
cut off point. 
 
In the third part of the thesis the consequences of IVF treatment on the 
psychological outcome were explored. In this part it was found that women showed 
an increase in both anxiety and depression after unsuccessful treatment. Since 
negative emotions seemed to disappear immediately after successful treatment, it 
was cautiously concluded that the stress of treatment is mainly determined by the 
threat of failure. Personality characteristics, preconceptions of the fertility problems 
and social support have been shown to determine the adjustment to unsuccessful 
IVF in women. This might allow early identification of women at risk for developing 
high levels of distress along with more tailored interventions. 
Six months after unsuccessful treatment, no improvement in the levels of anxiety 
and depression were evident. Moreover, at follow-up more than 20% of the women 
showed sub-clinical forms of anxiety and/or depression. It was concluded that most 
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women adjust well to unsuccessful treatment, but six months after the last 
treatment cycle a considerable part still showed substantial emotional problems. As 
a result a long term follow-up study was conducted, where the majority of the 
unsuccessfully treated women were again found to adept well psychologically. 
Regarding the whole group, anxiety and depression were found to return to baseline 
levels following unsuccessful treatment at long term (at least three years) follow-up. 
Although the high dropout rates during the study prevent firm conclusions and 
taking into account that selective dropout can never be excluded, still the results 
were reassuring.  
New life goals as a mode of adaptation were found to be related to lower levels of 
anxiety and depression in unsuccessful couples at follow-up. It is another 
contribution to the idea that long term psychological issues should be considered in 
becoming an integral part of general infertility care, as stated by Domar et al. 
(2004), but should also be considered in evaluating treatment outcome of IVF in 
particular. The findings may indeed lead to certain awareness in patients and 
colleagues, but also in health economists and policy makers, as this is vital for the 
funding of future care, interventions and additional research in this particular field. 
 
Successful treatment was found to result in a more positive emotional status six 
months after the IVF-cycle and was also found to persist at least three years later. 
This implies that it is not only successful treatment, but also having a child that 
leads to less anxiety and less depression, compared with the situation prior to 
treatment. Remarkable findings since IVF children bring along the same worries 
and are generally raised and treated in the same manner as other (not IVF) children 
(Barnes et al. 2004). This suggests no need for concern, for example about the issue 
of disclosure to the child (Greenfeld et al. 1996) and might be attributed to more 
satisfaction within the partnership (Ulrich et al. 2004). 
 
Future research 
Although this project is the first prospective, longitudinal study that integrates 
biomedical, gynaecological and psychological issues in a large cohort of women 
undergoing IVF, more data would obviously have led to more robust conclusions 
and the large dropout rate over time is an inherent, but methodological problem. 
Obviously, since correct prediction of the outcome of IVF treatment is unlikely with 
the current perceivable factors, the search for other, more accurate predictors 
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deserves our attention. However, from a clinical point of view a sceptical approach 
towards new predictors seems justified, as a prediction model which will give more 
insight (with clinical relevancy) into the prognosis of an individual patient, is still 
non-existent. 
The complex interplay between biomedical and psychological aspects of IVF 
treatment and the mechanisms, with particular respect to stresshormones, was a 
specific part of this thesis. Ideally, the combination of all known factors involved, 
i.e. hormonal, immunological, lifestyle and environmental in a prospective follow-up 
manner with more or less continuous measurements without dropout, would shed 
more light on these matters. Unfortunately this would imply that very large 
numbers of IVF patients would have to be studied in a ‘test tube’ setting, which is 
neither feasible nor desirable.  
Most women were found to adapt well to (un)successful IVF. However, one 
subgroup was found that seemed to be at risk of developing severe emotional 
problems at least three years after the last treatment cycle. The adaptation process 
to the treatment as a whole should be focussed on. Notably the transitional process 
from trying to get pregnant into giving meaning to ones life without a genetically 
own child, needs further prospective evaluation. Predicting those who develop 
problems is obviously difficult, but taking the impact into account this group 
deserves our full attention. Whether again this group (about 15% show (sub)clinical 
forms of anxiety and/or depression) would benefit from psychological interventions 
needs to be explored. Interventions could not only enhance or shorten the natural 
recovery process, but also lower the number of patients with anxiety and/or 
depression. Currently an intervention study using internet tools is being launched 
in our clinic to look into these matters. 
 
Clinical implications 
The well-being of the couples needs to be constantly in our focus. Treatment 
success is obviously important and success rates need to be optimal within certain 
boundaries. One has to bear in mind however that couples willingly undergo the 
hardships of treatment to strive for pregnancy. 
 
The boundaries need to be established together with the well-informed couple. The 
stimulation protocol, single embryo transfer and number of treatment cycles are 
mandatory items during the initial visit of the couple. These seemingly contradicting 
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aspects with respect to the outcome of treatment need special attention, as the 
reimbursement of up to three IVF treatment cycles were abolished in January 2004. 
Patients nowadays have to pay the first out of three IVF cycles themselves (unless 
otherwise insured) and as a result economical arguments seem to be more 
important than medical know-how. Whether this leads to a selection of better 
motivated couples or couples with a better prognosis is hypothetical. 
The new market based health system that was introduced in January 2006 in the 
Netherlands could even induce further detrimental health consequences in IVF 
treatment, since a focus shift is stimulated from quality to quantity. Increased 
competition could undermine the solidarity of the system, letting the unsuccessful 
patient pay the price for lean health care in the end. Patients with a poor prognosis 
could even be faced with exclusion from treatment in the future. Maybe we should 
advocate more clearly that we are ‘doctors with limits’ (Braat 2002), also 
considering this aspect of patient care. 
 
Participation of the couple in the decision taking process and more transparency of 
the treatment can enforce the feeling of self-control in couples, for instance by 
enabling internet access and as a result, low barriers to contact the treatment team 
(Haagen et al. 2003). Whether couples take on an active or a passive role in their 
own treatment for better coping is at their own choice, but their involvement needs 
to be triggered.  
Should we interfere? Intervention of the mental health team could be been as a way 
to optimise treatment, but also as an interference in a possibly self-protective 
process (Smeenk et al. 2004). Whether interference leads to higher rates of 
treatment success, lower dropout rates, or prevention of long term depression needs 
further exploration.  
Prior to treatment a ‘pre-IVF-visit’ to the doctor could be helpful to establish more 
clearly the boundaries of treatment and to present a clear and honest picture of the 
treatment, thereby avoiding misconceptions and pointing out alternative ways of 
adaptation. As a result of this thesis already a pre-IVF-visit has already been 
introduced as part of the standard IVF-protocol in our hospital.  
Furthermore, during treatment doctors should be sensitive to patient`s perceptions 
regarding the treatment. This could be discussed during treatment, but should at 
least be addressed in a scheduled visit following each treatment cycle, succesfull or 
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not. If (sub) clinical forms of anxiety and/or depression are being suspected, referral 
to an IVF-team psychologist should be discussed and advised with the couple.  
If a couple is on the waiting list and does not respond to the availability of starting 
treatment, a visit to a doctor might be offered to discuss the motives of 
postponement. In our clinic couples are contacted one year after unsuccessful 
treatment. We believe that this is not detrimental for their well-being or 
undermining their protective measures, but a reminder of the possibilities still 
available. Couples that want to maintain the option of returning to treatment can 
indicate that, without being forced to undergo treatment within a certain timeframe.  
After the last treatment cycle a concluding visit to the doctor should be an integral 
part of treatment and at that time it needs to be established whether couples might 
benefit from additional counselling following this visit. During this visit patients 
should also be informed that new life goals are associated with less distress in 
unsuccessful couples at long term follow-up. 
 
Overall we believe that the patient’s mental health should be considered an integral 
component of infertility care. A focus shift from the pure biomedical towards a 
broader approach could be strived for in order to improve the quality of care. In 
considering the whole treatment, as proposed by Heijnen et al. (2004) the 'term 
singleton birth rate per started IVF treatment in the overall context of patient 
discomfort, complications and costs' was introduced, which still seems limited to 
describe all aspects of treatment.  
 
More attention to the psychological repercussions of infertility treatment could 
surely lead to a more personalised approach and to improvement in patient 
satisfaction. The availability of a multidisciplinary team that holistically integrates 
medical and mental health during the treatment period, which extends over the 
period of regular appearances in the clinic, would be the first step.  
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Chapter 1 
General introduction and outline of the thesis.  
In the thesis three research goals are being dealt with:  
1. Study existing and new prognostic biomedical factors in IVF 
2. Study the integrated model of psychological and biomedical factors and the 
mechanisms involved on the course and outcome of IVF 
3. Study the consequences of IVF on the psychological outcome and discuss 
recommendations for the future 
 
Chapter 2 
In this chapter a study is presented in which we externally validated the prognostic 
model presented by Templeton (1996) for a live birth resulting from IVF treatment. 
Data were used from the University Hospital, Nijmegen, the Netherlands, from 
March 1991 to January 1999. The predictive capacity of the model in our 
population discriminated between a group of women that had a low probability of 
success and that had a relatively high probability. Despite these encouraging 
findings, our data show that implementation of the model in clinical decision 
making remains difficult. The ‘Templeton’ model is not applicable nor usable in 
daily clinical practice, because the model did not give more information about the 
prognosis for the vast majority of the patients. The search for better prognostic 
factors resulting in better predictive models should therefore continue.  
 
Chapter 3 
In this chapter a relative new marker, Antimullerian hormone (AMH) was compared 
with other alleged predictors of treatment outcome. On day three of the cycle 
preceding the first IVF cycle several factors were assessed. In 112 consecutive IVF 
cycles, 40 viable pregnancies were achieved (36%). These 40 patients were 
compared with 40 randomly selected women out of the 72 remaining women 
without a pregnancy. None of the biomedical, echoscopic and hormonal factors 
showed predictive capacity with respect to pregnancy after treatment. AMH 
concentrations in serum proved to be the best predictor of ovarian responsiveness. 
However, a large variation was observed in AMH concentrations which limit the 
clinical applicability. 
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Chapter 4 
In this chapter the predictive value of FSH-isoforms for the outcome of IVF 
treatment was analysed. We hypothesized that not the quantity, but the quality of 
basal FSH would be predictive. In order to test the hypothesis two ‘extreme’ groups 
were compared; a relatively young group with normal basal FSH levels and a good 
response to 150 IU of recombinant FSH and a relatively old group with normal 
basal FSH levels and a poor response to 300 IU of recombinant FSH. No statistical 
differences could be found in the isoform-composition between the two groups. 
Differences were found in the number of antral follicles and Inhibin B concentration 
in blood collected before the treatment. Although this pilot study comprises only ten 
patients, we conclude that it is not likely that FSH-isoforms predict treatment 
outcome after IVF 
 
Chapter 5  
In this chapter a study aimed to clarify the role of depression and anxiety on the 
outcome in assisted reproductive treatment is presented. Previous studies on this 
topic have shown contradicting results, which may have been caused by population 
characteristics, the design of the study, or small sample sizes. In a multicentre 
prospective study 281 out of 359 (81%) consecutively invited women were willing to 
take part. Before down-regulation by means of GnRH-analogues in a long IVF-
protocol, patients were asked to fill out the Dutch version of the State and Trait 
Anxiety Inventory to measure anxiety and the Dutch version of the Beck Depression 
Inventory (BDI) to measure depression. Pre-existing psychological factors were 
found to be independently related to treatment outcome in IVF and should therefore 
be taken into account in patient counselling. Psychological factors may be improved 
by intervention, whereas demographic and gynaecological factors cannot.  
 
Chapter 6 
In this chapter a study was presented in order to gain more insight into 
psychological aspects of dropping out in IVF. In a prospective cohort study, 380 
women entering their first treatment cycle of IVF or ICSI were enrolled. 
Standardized psychological questionnaires were administered before the start of the 
treatment and after treatment. Base-line psychological factors and the probability of 
dropout after IVF treatment were found to be associated in the group that stopped 
treatment for psychological reasons. Those who were denied further treatment by 
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the medical team, the ‘actively censored’ group, did not show pretreatment 
differences regarding psychological measures in comparison with those who 
continued treatment. After treatment, the group that was denied further treatment 
showed higher levels of anxiety and depression compared to those that continued. 
Dropout, being a well-known phenomenon in IVF, was found to be related to pre-
existing psychological factors in IVF.  
 
Chapter 7 
In this chapter a study was presented that examined the associations between the 
stress hormones adrenaline, noradrenaline and cortisol in urine during treatment 
with the self reported stress, in order to investigate the mechanism for the 
previously observed negative association of anxiety and depression with the 
outcome of IVF. In a multicentre prospective cohort study, 168 women entering 
their first cycle of IVF treatment were enrolled. From each participant three 
nocturnal urine samples were collected; pre-treatment, before ovum-pickup (OPU) 
and before embryo-transfer (ET). Additionally, two questionnaires were 
administered before the start of the treatment to measure anxiety and depression. A 
significant positive correlation between urinary adrenaline concentrations at 
baseline and ET and the scores on depression at baseline were found. In women 
with successful treatment lower concentrations of adrenaline at OPU and lower 
concentrations of adrenaline and noradrenaline at ET, compared with unsuccessful 
women, were found. The significant association of adrenaline concentration with 
pregnancy and with depression suggested that this adrenal hormone could be one 
of the links in the complex relationship between psychosocial stress and outcome 
after IVF.  
 
Chapter 8 
In this chapter study into the course of the emotional response to IVF from pre-
treatment to six months post-treatment and factors that contributed to that course 
was presented. In a longitudinal prospective study 148 IVF patients and 71 
partners completed self-report questionnaires. Assessments of anxiety and 
depression were repeated immediately following the final treatment cycle and again 
six months later. Women showed an increase of both anxiety and depression after 
unsuccessful treatment and a decrease after successful treatment. Men showed no 
change in anxiety and depression neither after successful nor after successful 
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treatment. In the six months after unsuccessful treatment, women showed no 
recovery. At follow-up, more than 20% of the women showed sub-clinical forms of 
anxiety and/or depression. Personality characteristics, meaning of the fertility 
problems, and social support determined the course of the emotional response, 
which allows early identification of women at risk as well as tailored interventions.  
 
Chapter 9 
In this chapter a prospective cohort study was presented aiming at of the gain of 
more insight into long term psychological adjustment to unsuccessful treatment in 
IVF. Two-hundred-ninety-eight women (78% of the participants) completed the last 
set of questionnaires 3 to 5 years after treatment. 193 women were successful in 
achieving a pregnancy, 105 women were unsuccessful. Anxiety and depression were 
found to return to baseline levels following unsuccessful treatment at follow-up 
after an initial increase during treatment. On the other hand successful treatment 
was found to result in a more positive long term emotional status. New life goals as 
mode of adaptation 3 to 5 years after IVF were found to be related to lower levels of 
anxiety and depression at that time. The majority of the unsuccessfully treated 
women were found to psychologically adept well. Positive adjustment was related to 
developing new life goals in contrast to persisting in attempts to get pregnant. 
 
Chapter 10 
In this chapter an epilogue is presented with some concluding remarks regarding 
the studies presented. Clinical applicability of the findings and recommendations 
for future research are being discussed. It was concluded that more attention to the 
psychological repercussions of infertility treatment could lead to a more 
personalised approach and to improvement of patient’s satisfaction. The availability 
of a multidisciplinary team that holistically integrates medical and mental health 
during the treatment period, which extends the period of regular appearances in the 
clinic, would be the first step. 
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Hoofdstuk 1 
Algemene inleiding en indeling van het proefschrift. In het proefschrift worden drie 
onderzoeksdoelen behandeld; 
1. Bestaande en nieuwe prognostische biomedische factoren in IVF onderzoek 
2. Een geïntegreerd model bestuderen van psychologische factoren en 
biomedische factoren op het beloop en de uitkomst van IVF 
3. De gevolgen van IVF behandeling op de psychologische uitkomst onderzoeken 
en aanbevelingen voor de toekomst bespreken 
 
Hoofdstuk 2 
In dit hoofdstuk wordt er een studie gepresenteerd waarin het prognostische model 
voor een levendgeborene na IVF, zoals dat door Templeton is gepubliceerd (1996), 
extern wordt gevalideerd. Data werden gebruikt van de Radboud Universiteit, 
Nijmegen, Nederland, van maart 1991 tot januari 1999. De voorspellende capaciteit 
van het model in onze populatie maakte onderscheid tussen een groep vrouwen me 
een lage succeskans en een relatief hoge succeskans. Ondanks deze bemoedigende 
bevindingen, tonen onze data aan dat implementatie van het model bij het maken 
van klinische beslissingen moeilijk blijft. Het 'Templeton' model is derhalve niet 
toepasbaar of bruikbaar in de dagelijkse praktijk, omdat het model niet meer 
informatie gaf omtrent de prognose voor veruit het grootste deel van de patiënten. 
De zoektocht naar betere prognostische factoren wat zouden kunnen resulteren in 
betere voorspellende modellen dient daarom door te gaan. 
 
Hoofdstuk 3 
In dit hoofdstuk wordt een relatief nieuwe marker, het Anti-Mullerian hormoon 
(AMH) vergeleken met andere vooronderstelde voorspellers van de 
behandelingsuitkomst. Op dag drie van de cyclus voorafgaande aan de eerste IVF 
cyclus werden verscheidene factoren bepaald. In 112 IVF cycli kwam het tot 40 
doorgaande zwangerschappen (36%). Deze 40 patiënten werden vergeleken met 40 
patiënten welke random werden geselecteerd uit de 72 overige vrouwen zonder een 
zwangerschap. Van geen van de biomedische, echoscopische and hormonale 
factoren werd voorspellende waarde aangaande zwangerschap na behandeling 
aangetoond. Van AMH concentraties in serum werd gevonden dat deze de ovariële 
respons konden voorspellen, als enige van de onderzochte factoren. Een grote 
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variatie werd gevonden voor AMH concentraties, wat de klinische toepasbaarheid 
beperkt.  
 
Hoofdstuk 4 
In dit hoofdstuk is de voorspellende waarde van Follikel stimulerend hormoon 
(FSH)-isovormen m.b.t. de uitkomst van de IVF behandeling onderzocht. Onze 
hypothese luidde dat FSH niet zozeer kwantitatief alsmede kwalitatief voorspellend 
zou kunnen zijn m.b.t. de uitkomst van de behandeling. Om de hypothese te testen 
werden twee 'extreme' groepen vergeleken; een relatief jonge groep met normale 
basale FSH waarden met een goede respons op 150 eenheden recombinant FSH 
tijdens behandeling en een relatief oude groep met normale basale FSH waarden en 
een slechte respons op 300 eenheden recombinant FSH. Statistisch konden geen 
verschillen in de isovorm samenstelling tussen beide groepen worden gevonden. 
Verschillen werden gevonden in het aantal antrale follkels en Inhibine B 
concentraties in bloed dat werd verzameld voorafgaande aan de behandeling. 
Hoewel deze pilot studie slechts uit tien patienten bestaat, concluderen wij dat het 
niet waarschijnlijk is dat FSH-isovormen de uitkomst van IVF kunnen voorspellen. 
 
Hoofdstuk 5 
In dit hoofdstuk wordt een studie gepresenteerd welke is uitgevoerd om de rol van 
angst en depressie op de uitkomst van geassisteerde voortplanting te 
verduidelijken. Voorafgaande studies die zich met deze materie hebben 
beziggehouden hebben tegenstrijdige resultaten laten zien, welke kunnen zijn 
veroorzaakt door populatie kenmerken, studie opzet of kleine groepen. In een 
multicentre prospectieve studie waren 281 van de 359 benaderde patiënten (81%) 
bereid om deel te nemen aan het onderzoek. Voorafgaande aan de down-regulatie 
met behulp van GnRH analogen in een lang IVF-protocol, werden patiënten 
gevraagd om de State en Trait Anxiety Inventory en de Beck Depression Inventory 
(BDI) vragenlijsten in vullen om respectievelijk angst en depressie te meten. Vooraf 
aanwezige psychologische factoren bleken onafhankelijk gerelateerd aan de 
uitkomst van de IVF behandeling en zouden daarom betrokken moeten worden in 
de counselling van patiënten. Psychologische factoren kunnen wellicht beïnvloed 
worden door interventies, demografische en gynaecologische factoren echter niet. 
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Hoofdstuk 6 
In dit hoofdstuk staat een studie beschreven die meer inzicht tracht te verschaffen 
over de psychologische aspecten van uitval tijdens IVF. In een prospectieve cohort 
studie werden 380 patiënten die voor de eerste behandelingscyclus van IVF 
kwamen geïncludeerd. Gestandaardiseerde psychologische vragenlijsten werden 
afgenomen voorafgaande aan de behandeling en na afloop van de behandeling. 
Baseline psychologische factoren en de uitvalskans na IVF bleken geassocieerd in 
de groep die aangaf met de behandeling te zijn gestopt om psychologische redenen.  
De patiënten die verdere behandeling werd ontzegd liet voorafgaand geen verschillen 
op psychologisch gebied zien vergeleken met hen die de behandeling voorzetten. 
Volgend op de behandeling gaf de groep die verdere behandeling was ontzegd wel 
meer angst en depressie aan vergeleken met hen die doorgingen. Uitval, een bekend 
fenomeen tijdens de IVF behandeling, bleek gerelateerd aan voorafgaande 
psychologische factoren.  
 
Hoofdstuk 7 
In dit hoofdstuk wordt een studie behandeld die de relatie tussen de stress 
hormonen adrenaline, noradrenaline en cortisol in urine met de zelf aangegeven 
stress tijdens een behandeling onderzoekt om het mechanisme te onderzoeken voor 
de eerder beschreven negatieve associatie tussen angst en depressie en de uitkomst 
van IVF. In een multicentre prospectieve cohort studie werden 168 vrouwen die voor 
hun eerste IVF behandelingscyclus kwamen geïncludeerd. Van elke deelneemster 
werden drie nachtelijke urinemonsters verzameld; voorafgaande aan de 
behandeling, voorafgaande aan de punctie en voorafgaande aan de embryotransfer. 
Tevens werden twee vragenlijsten afgenomen voorafgaande aan de behandeling om 
angst en depressie te meten. Een significante positieve correlatie tussen de urinaire 
adrenaline concentraties voorafgaand aan de behandeling en embryotransfer en de 
depressie scores voorafgaande aan de behandeling werd gevonden. Bij vrouwen bij 
wie de behandeling succesvol was werden in vergelijking met de vrouwen waarbij de 
behandeling niet tot zwangerschap leidde lagere adrenaline concentraties ten tijde 
van de punctie en lagere concentraties adrenaline en noradrenaline ten tijde van de 
embryotransfer. De significante associatie tussen adrenaline concentraties met 
zwangerschap enerzijds en met depressie anderzijds geeft aan dat dit hormoon een 
van de schakels zou kunnen zijn in de complexe relatie tussen psychosociale stress 
en de uitkomst na IVF. 
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Hoofdstuk 8 
Dit hoofdstuk beschrijft een longitudinale studie waarin de emotionele respons 
wordt beschreven op de IVF behandeling van voorafgaand aan de behandeling tot 
zes maanden na de behandeling waarbij de factoren die bijdragen aan dat beloop 
worden gepresenteerd. 148 IVF patiënten en 71 van hun partners vulden de 
vragenlijsten in. Angst en depressie werden direct volgend op de laatste 
behandelingscyclus gemeten en vervolgens zes maanden hierna. Bij vrouwen 
werden een toename van zowel angst als depressie gevonden volgend op niet 
succesvolle behandeling en een afname na succesvolle behandeling. Mannen 
toonden geen verandering in zowel angst als depressie of het nu wel of niet een 
succesvolle behandeling betrof. In de zes maanden volgend op de niet succesvolle 
behandeling werd er bij de vrouwen geen verbetering gevonden.  
Ten tijde hiervan werd bij 20% van de vrouwen subklinische vormen van angst 
en/of depressie gevonden. Persoonlijkheidskenmerken, de betekenis welke gegeven 
wordt aan fertiliteitproblemen en sociale ondersteuning bepaalden het beloop van 
de emotionele respons. Dit stelt ons wellicht in staat om de vrouwen die at risk zijn 
vroeg te identificeren en passend te interveniëren. 
 
Hoofdstuk 9 
Een prospectieve cohort studie wordt in dit hoofdstuk gepresenteerd waarin 
getracht wordt meer inzicht te verkrijgen in lange termijn psychologische 
aanpassing aan onsuccesvolle IVF behandeling. De laatste set vragenlijsten werd 3 
tot 5 jaar na de laatste behandeling door 298 deelneemsters ingevuld (78%). 193 
vrouwen kregen een kind, 105 vrouwen niet. Angst en depressie bleken naar 
uitgangsniveau terug te keren volgend op onsuccesvolle behandeling na een in 
hoofdstuk 8 beschreven initiële stijging. Aan de andere kant bleek succesvolle 
behandeling te resulteren in een positievere emotionele status. Nieuwe levensdoelen 
zoals de aanpassingsmanier 3 tot 5 jaar na IVF bleken gerelateerd aan minder 
angst en depressie op dat moment. De meerderheid van onsuccesvol behandelde 
vrouwen bleek zich psychologisch goed aan te passen. Positieve aanpassing bleek 
gerelateerd aan het ontwikkelen van nieuwe levensdoelen, het persisteren in het 
proberen om zwanger te raken bleek hier haaks op te staan. 
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Hoofdstuk 10 
In dit hoofdstuk wordt een epiloog beschreven met enkele concluderende 
opmerkingen betreffende de gepresenteerde studies. Klinische toepasbaarheid van 
de bevindingen en aanbevelingen voor toekomstig onderzoek worden besproken. 
Meer aandacht voor de psychologische repercussies zouden tot een meer 
persoonlijke benadering en tot toename van de tevredenheid van patiënten 
aanleiding kunnen geven. De beschikbaarheid van een multidisciplinair team dat 
zowel aandacht heeft voor medische en geestelijke aspecten van de behandeling, 
zowel tijdens maar ook na de periode waarin de kliniek regelmatig wordt bezocht, 
zou de eerste stap zijn. 
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Wetenschap is als een individualistische teamsport en een proefschrift is dan ook 
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van dank aan allen die in enigerlei mate hebben bijgedragen in de totstandkoming 
van dit proefschrift.  
Vooreerst een woord van dank aan alle paren die mee wilden werken aan het 
onderzoek, zonder hun inzet en uithoudingsvermogen (!) was dit onderzoek 
spreekwoordelijk niet mogelijk geweest… 
 
Grote dank ben ik verschuldigd aan het ‘projectteam’ welke binnen een 
multidisciplinaire setting voor een gedegen, nauwgezette begeleiding, voorafgaand 
en tijdens het project hebben zorggedragen.  
Meer in het bijzonder wil ik mijn (co) promotores danken; 
Professor dr D.D.M. Braat, beste Didi, via een wetenschappelijke stage maakten we 
kennis en direct aansluitend aan een stage in Tanzania mocht ik gaan participeren 
in het promotieonderzoek. Zowel qua vorm als inhoud een uitdagend geheel. 
Dankzij jouw enthousiasme, vastberadenheid en tact ben ik in meerdere opzichten 
zover gekomen. Dank voor je steun en vertrouwen de voorbije jaren, al nam ik 
wellicht wat veel tijd. 
Professor dr F. Kraaimaat, beste Floor, via dit project leerden we elkaar kennen en 
gaandeweg heb ik door jouw nauwgezette begeleiding de psychologische 
achtergronden leren kennen. Psychologie was een terra incognita en hoewel ik 
slechts oppervlakkig heb kunnen ‘snuffelen’ ben ik het vak zeer gaan waarderen. 
Dr J.A.M. Kremer, beste Jan, hoofd van de pijler Fertendo. Je stond en staat altijd 
garant voor een feilloze organisatie, soepele voortgang en buitengewoon goede sfeer 
binnen het Fertendo team. Een longitudinaal onderzoek als dit was zonder deze 
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bondige commentaren waren van grote waarde. 
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CAL Hoogduin, Prof dr AJJM Vingerhoets, Prof dr G Zielhuis, Dr Antje Eugster. In 
dit kader een extra woord van dank aan prof dr JMWM Merkus die aan de wieg 
stond van het gehele project. (staat de jenever nog altijd koud?) Kortom 
multidisciplinaire samenwerking in optima forma waarbij de veelheid aan 
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perspectieven uiteindelijk tot een wetenschappelijk zeer vruchtbaar klimaat 
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bepalingen, maar ook voor het meedenken omtrent de methodologie, de logistiek 
van de bepalingen (bokalen!), het meeschrijven aan artikelen, etc. In het bijzonder 
wil ik noemen Rob van de Berg, Fred Sweep, Chris Thomas, Jacques Willemsen, 
naast al die anderen die betrokken waren bij het meten. 
 
Prof. Gerhard Zielhuis en Dr. Huub van der Straaten van de afdeling biostatistiek 
en informatiekunde, jullie professionele ondersteuning bij statistische en 
methodologische vraagstukken bleek eens te meer onontbeerlijk. Annete Stolwijk, 
thans werkzaam op de afdeling medische zaken, maakte mij wegwijs in de wondere 
wereld van modellen en validatie hiervan. Het was uitdagende materie, dank voor je 
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Annemarie, Cathelijne, Erik, Iris, Marcel, Michael, Pascal, Petra, Ron, Ruben, 
Sabina, Tanya, Wai Yee en Willianne. Collegae: het was een mooie tijd..  Maar ook 
de huidige generatie onderzoekers, meer in het bijzonder Irene, Dennis, Esther en 
Anika, dank voor jullie ondersteuning (pdf-service). Speciaal in dit kader te noemen 
zijn de voormalige bewoners van de gezamelijke werkplek ‘de vissenkom’ met wie 
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over de jaren een warme band is ontstaan, Eva Maria, René en Marieke. Voorwaar 
een vruchtbare plek!  
Last but not least: Mark, dank voor je ondersteuning en daarnaast je prikkelende, 
competatieve instelling. 
 
Tevens uiteraard een woord van dank aan alle assistenten, gynaecologen, 
verpleegkundigen, poli-medewerkers, secretaresses van de afdelingen gynaecologie 
van de Radboud Universiteit en uiteraard evenzo van het Canisius Wilhelmina 
Ziekenhuis. Meer in het bijzonder alle betrokkenen van het ‘Fertendo’ team, het was 
een eer deel uit te maken van deze hechte club. 
 
Medewerkers van de afdeling medische psychologie, jullie hebben me altijd welkom 
opgenomen in jullie gelederen en de samenwerking was buitengewoon aangenaam! 
In het bijzonder dank aan het secretariaat, Nancy van der Steeg, Inger Stokkink en 
Helma Wouters. Daarnaast Ria te Winkel, rots in de branding omtrent de logistiek 
van de datavergaring. Een bibliotheek vol met datafiles, mede dankzij het noeste 
invoerwerk van Joyce de Bruin en Koen te Winkel. 
 
Vrienden en bekenden, dank voor jullie steun en nimmer aflatende aandacht voor 
het thema ‘promoveren’. Erik, Rienk, Martijn, Raymond (lay out!), Patrick, Sander, 
Maurits, Bart: tijd om een glas Islay whisky te heffen, ditmaal echter op de 
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Mijn ouders wil ik danken voor hun onvoorwaardelijke steun en liefde, die heeft 
zorg gedragen voor de benodigde ontplooiing en ontwikkeling. Het warme nest met 
René, Nicole, Priscilla en Koen zorgde voor een vertrouwde basis om altijd op terug 
te kunnen vallen. Het is en blijft goed toeven op het ‘platte land’. Uiteraard ook 
dank voor de steun vanuit het zuiden des lands in deze. 
 
Lieve Petra, Punky heeft het af. Dank voor alle steun en liefde, opdat we nog heel 
lang samen mogen genieten.  
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